<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Iran J Basic Med Sci</journal-id><journal-id journal-id-type="iso-abbrev">Iran J Basic Med Sci</journal-id><journal-id journal-id-type="publisher-id">ijbms</journal-id><journal-title-group><journal-title>Iranian Journal of Basic Medical Sciences</journal-title></journal-title-group><issn pub-type="ppub">2008-3866</issn><issn pub-type="epub">2008-3874</issn><publisher><publisher-name>Mashhad University of Medical Sciences</publisher-name><publisher-loc>Mashhad, Iran</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">8087850</article-id><article-id pub-id-type="doi">10.22038/ijbms.2021.48965.11218</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>The protective effect of <italic>Azadirachta indica</italic> (neem) against metabolic syndrome: A review</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Yarmohammadi</surname><given-names>Fatemeh</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Mehri</surname><given-names>Soghra</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Najafi</surname><given-names>Nahid</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Salar Amoli</surname><given-names>Sanaz</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Hosseinzadeh</surname><given-names>Hossein</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib></contrib-group><aff id="aff1">
<label>1</label>Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran</aff><aff id="aff2">
<label>2</label>Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran</aff><aff id="aff3">
<label>3</label>Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran</aff><aff id="aff4">
<label>4</label>Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran</aff><author-notes><corresp id="cor1"><label>*</label>Corresponding author: Hossein Hosseinzadeh. Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences (MUMS), Mashhad, Islamic Republic of Iran. Tel: +98-51-38819042, Fax: +98-51-38823251; Email: hosseinzadehh@mums.ac.ir</corresp></author-notes><pub-date pub-type="ppub"><month>3</month><year>2021</year></pub-date><volume>24</volume><issue>3</issue><fpage>280</fpage><lpage>292</lpage><history><date date-type="received"><day>21</day><month>5</month><year>2020</year></date><date date-type="accepted"><day>4</day><month>11</month><year>2020</year></date></history><permissions><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/3.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/3.0/">http://creativecommons.org/licenses/by/3.0/</ext-link>) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Metabolic syndrome is a condition associated with obesity, diabetes, dyslipidemia, and high blood pressure. Recently, the use of phytochemicals is suggested in the control and treatment of metabolic syndrome. The <italic>Azadirachta indica</italic> (neem) is an evergreen tree belonging to the family of Meliaceae. Multiple studies have been confirmed the anti-diabetic and anti-hypertension, anti-hyperlipidemia, and anti-obesity effects of neem. In this review, we reported the protective effects of neem against the complications of metabolic syndrome with a special focus on mechanisms that are involved. It has been shown that neem can control hyperglycemia and hypertension through over-expression of transcription factor nuclear factor erythroid 2&#x02013;related factor 2 (Nrf2) and anti-oxidant effects. Neem also reduced the glucose uptake through up-regulation of glucose transporter 4 (GLUT4) and inhibition of key intestinal enzymes such as glucosidases. Moreover, neem showed anti-hypertensive effects possibility via the block of calcium channels, up-regulation of endothelial nitric oxide synthase (eNOS), and extracellular signal-regulated kinases 1/2 (ERK1/2) signaling pathway. Anti-oxidant effects play an important role in protective mechanisms of neem against metabolic syndrome and its complications.</p></abstract><kwd-group><title>Key Words</title><kwd>Azadirachta indica</kwd><kwd>Diabetes</kwd><kwd>Hyperlipidemia</kwd><kwd>Hypertension</kwd><kwd>Metabolic syndrome</kwd><kwd>Neem</kwd><kwd>Obesity</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Metabolic syndrome (MetS) is a common metabolic disorder that is described for more than multiple decades. The MetS is also known as insulin resistance syndrome and syndrome X (1). Physical inactivity, smoking, increasing age, obesity, and positive family history are risk factors associated with its development (<xref rid="B2" ref-type="bibr">2</xref>). Epidemiologic data have been suggested that the prevalence of MetS among the population over 60 years is the highest, and it is increasing among children and adolescents (<xref rid="B3" ref-type="bibr">3</xref>). People with MetS have a higher risk of type 2 diabetes and cardiovascular disease (CVD) (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B5" ref-type="bibr">5</xref>). Also, hypertension and an increase in triglyceride (TG)/high-density lipoprotein (HDL) cholesterol ratio are important components of the MetS and are one of the most risk factors for CVD (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B7" ref-type="bibr">7</xref>).</p><p>Moreover, several studies have been shown other side effects of MetS such as fatty liver disease (<xref rid="B8" ref-type="bibr">8</xref>), cirrhosis (<xref rid="B9" ref-type="bibr">9</xref>), and polycystic ovary syndrome (<xref rid="B10" ref-type="bibr">10</xref>). The pathogenesis of MetS has not been clearly defined, but insulin resistance, oxidative stress, and chronic inflammation are key pathogenic factors of it. Insulin resistance has a role in the development of diabetes mellitus. It has been reported that oxidative stress accelerates the development of complications of MetS. The activation of the inflammatory pathway leads to insulin resistance and diabetes (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B12" ref-type="bibr">12</xref>).</p><p>The first-line treatment of MetS is lifestyle modification on diet, weight, and physical activity. Second-line therapy for patients with MetS is drug therapy (<xref rid="B13" ref-type="bibr">13</xref>). In line with the treatment of MetS, the use of herbs has been regarded. Medicinal plants contain bioactive compounds with various metabolic effects. In several studies have been reported the protective potential of plants and herbs against MetS such as&#x000a0;<italic>Capsicum</italic>&#x000a0;<italic>annuum</italic>&#x000a0;L. (<xref rid="B14" ref-type="bibr">14</xref>), <italic>Crataegus</italic>
<italic>pinnatifida</italic> (<xref rid="B15" ref-type="bibr">15</xref>), and green tea (<xref rid="B16" ref-type="bibr">16</xref>). Taken together, the management of complications of MetS is the aim of the treatment in these patients, and medicinal plants can play an important role in its treatment.</p><p>Neem (<italic>Azadirachta</italic>&#x000a0;<italic>indica</italic>) is an evergreen tree of southeastern Asia that is widely distributed in the Indian subcontinent. The height of this tree is approximately 15-20 m and sometimes even up to 35-40 m. The word&#x000a0;<italic>A. indica</italic>&#x000a0;was derived from the Persian language. The Azad means &#x0201c;free,&#x0201d; and the dirakht is meaning &#x0201c;tree,&#x0201d; and &#x0201c;I&#x0201d; refer to &#x0201c;Indian origin.&#x0201d; (<xref rid="B17" ref-type="bibr">17</xref>). Neem is a common name, and also it&#x02019;s known with the name of Nimbay, Veppai, Ariyaveppu, Vepa in India (<xref rid="B18" ref-type="bibr">18</xref>). More than 300 compounds are derived from different parts of neem, such as leaves, flower, seed, fruit, bark, and root. Non-isoprenoids and isoprenoids metabolites are two major groups of these compounds. Some active constituents of neem include nimbidin, sodium nimbidate, nimbin, nimbolide, gallic acid, azadirachtin, and polysaccharides (<xref rid="B19" ref-type="bibr">19</xref>). Nimbidin, as a major constituent extracted from neem seeds, demonstrated several biological activities such as anti-inflammatory, anti-pyretic, anti-diabetic, anti-fungal, and anti-ulcer activities. The spermicidal activity of nimbin has been reported in humans. Nimbolide has been shown to exert anti-malaria and antibacterial effects (<xref rid="B20" ref-type="bibr">20</xref>). Several studies have been reported the different pharmacologic effects of neem, including hypolipidemic (<xref rid="B21" ref-type="bibr">21</xref>), hepatoprotective (<xref rid="B22" ref-type="bibr">22</xref>), antimicrobial, anticancer, and anti-diabetes (<xref rid="B23" ref-type="bibr">23</xref>) properties. In line with these properties, the US National Academy of Science (NAS) has stated the neem tree as a tree that is solving global problems (<xref rid="B24" ref-type="bibr">24</xref>). On the other hand, neem oil has shown vomiting, diarrhea, acidosis, drowsiness, and encephalopathy in human studies. Also, mild to severe changes in the liver, intestine, spleen, kidney, and heart of chick and genotoxicity and anti-fertility in mice and rats by neem leaves and seeds have been reported. Neem leaf extract also decreased sperm count and sperm motility, probably due to androgen deficiency. Nimbolide has induced the kidney, small intestine, liver dysfunction, and blood pressure drop suddenly in animals (<xref rid="B20" ref-type="bibr">20</xref>). This review focuses on the effects of neem in treatment of diabetes, high blood pressure, dyslipidemia, and obesity. </p><p>
<bold><italic>Methodology</italic></bold>
</p><p>The databases of PubMed, Scopus, and Google Scholar have been involved in this review. Articles have been collected from the date of inception up to January 2020. The search keywords included metabolic syndrome, hypertension, blood pressure, hypotensive, antihypertensive, dyslipidemia, hyperlipidemia, high cholesterol, high triglyceride, hypercholesterolemia, hypertriglyceridemia, atherogenic, atherosclerosis, obesity, overweight, appetite, anti<italic>-</italic>obesity, weight loss, diabetes, hyperglycemia, insulin, hypoglycemic, antihyperglycemic, antidiabetic, blood glucose, neem, and <italic>Azadirachta</italic>&#x000a0;<italic>indica</italic>.</p><p>
<bold><italic>Effects of neem on metabolic syndrome</italic></bold>
</p><p>
<italic>Effects of neem on high blood pressure</italic>
</p><p>One of the main constituents of MetS is high blood pressure (BP). Effects of several plants investigated on BP such as <italic>Aloe vera</italic> (<xref rid="B25" ref-type="bibr">25</xref>) and <italic>Capsicum annuum</italic> L. (<xref rid="B14" ref-type="bibr">14</xref>). High BP has an increased risk of heart and blood vessel diseases. Multiple mechanisms induce high BP, including: (1) Calcium channels initiate vascular smooth muscle contraction through the release of calcium, which is mediated by Ca<sup>2+ </sup>influx via L-type and voltage-gated calcium channels. Calcium channels have an important role in the induction of high BP (<xref rid="B26" ref-type="bibr">26</xref>); (2) the extracellular signal-regulated kinase (ERK 1 and 2) are from the mitogen-activated protein kinases (MAPK) family. ERK1 and ERK2 play an essential role in the regulation of vascular smooth muscle contraction. Down-regulation of ERK 1 and 2 genes reduces both vascular smooth muscle cell growth and vasoconstriction. Therefore, ERK 1and 2 are a target for the induction of high BP (<xref rid="B27" ref-type="bibr">27</xref>); (3) Nitric oxide (NO) is a vasodilator produced by nitric oxide synthase (NOS) enzymes. The NOS isozymes and NO level are candidates for involvement in high BP (<xref rid="B28" ref-type="bibr">28</xref>); (4) Nuclear factor erythroid 2&#x02013;related factor 2 (Nrf2) as a transcription factor involves transcriptional induction of several anti-oxidant genes. Nrf2 regulates signaling pathway functions to reduce reactive oxygen radicals (ROS) production. The down-regulation of Nrf2 expressions induces ROS production and resulting in high BP. The contraction of smooth muscle and depletion of NO are the mechanisms of ROS-induced high BP (<xref rid="B29" ref-type="bibr">29</xref>). Several studies have been reported the beneficial effects of different extracts (aqueous, alcoholic) of neem leaves against high BP which have been categorized in <xref rid="T1" ref-type="table">Table 1</xref>. The mechanisms underlying the protective effect of neem against high BP have been presented in <xref ref-type="fig" rid="F1">Figure 1</xref>. The mechanisms are including the block of calcium channels (<xref rid="B30" ref-type="bibr">30</xref>), up-regulation of ERK 1 and 2 (<xref rid="B31" ref-type="bibr">31</xref>) and Nrf2 gene expression, reduction of oxidative stress markers, and elevation of the nitric oxide (NO) levels (<xref rid="B32" ref-type="bibr">32</xref>). It has been reported that neem exerted the vasodilatation effects possibility through the block of calcium channel in the isolated aorta of rat and rabbit. Also, it has been shown that neem exerted dose-dependent fall in arterial pressure of isolated guinea-pig atrial (<xref rid="B30" ref-type="bibr">30</xref>). The down-regulation of ERK1 and 2 have been reported in cardiac and renal tissues of rats treated by sodium fluoride (600 ppm in drinking water). Neem protected hypertensive rats through (100 and 200 mg/kg, p.o.) up-regulation of ERK (<xref rid="B31" ref-type="bibr">31</xref>). L-NAME (N &#x003c9; -Nitro-L-Arginine Methyl Ester) is a NOS inhibitor and reduces NO bioavailability. Polyphenol-rich fraction of neem (100 and 200 mg/kg) restored NO level in rats were treated with L-NAME (orally, 40 mg/kg) (<xref rid="B32" ref-type="bibr">32</xref>). The methanol extract of neem (orally, 100 and 200 mg/kg for 7 days) increased NO level in serum of rats exposed to sodium fluoride (NaF) (600 ppm in drinking water) (<xref rid="B31" ref-type="bibr">31</xref>). The crude (0.3-3 mg/ml), aqueous (1-5 mg/ml) and ethyl acetate (0.1-1 mg/kg) extracts of neem induced endothelium-dependent vasorelaxation in isolated rat aorta (<xref rid="B30" ref-type="bibr">30</xref>). </p><p>Neem restored anti-oxidant enzyme activity, including superoxide dismutase (SOD), glutathione peroxidase (GPx), and glutathione S-transferase (GSTs) in animal models of high BP. Neem also improved glutathione (GSH) and reduced malondialdehyde (MDA) and protein carbonyl (markers of oxidative stress) levels (<xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B32" ref-type="bibr">32</xref>). The aqueous extract of neem (20 mg/kg) reduced mean arterial pressure in rats which were treated by DOCA-salt (15 mg/kg, s.c.) and drinking water containing 1.0% NaCl and 0.03% KCl (<xref rid="B33" ref-type="bibr">33</xref>).</p><p>A study has been reported on the effect of neem leaves on high BP of the 90 diabetic patients aged 40-60, which were kept under observation for a month. During&#x000a0;the&#x000a0;study, patients received 2 g powder of neem daily for three months. A significant reduction was observed in the BP of treated patients (<xref rid="B34" ref-type="bibr">34</xref>).</p><p>
<italic>Effects of neem on hyperlipidemia</italic>
</p><p>One of the most components of MetS is hyperlipidemia. Many medicinal plants showed positive effects on hyperlipidemia such as barberry (<italic>Berberis vulgaris</italic>) (<xref rid="B35" ref-type="bibr">35</xref>) and rosemary (<italic>Rosmarinus officinalis</italic>) (<xref rid="B36" ref-type="bibr">36</xref>). Plasma lipid levels elevate in people with diabetes and obesity (<xref rid="B37" ref-type="bibr">37</xref>). Hyperlipidemia contributes to impair endothelial function, development of atherosclerosis, and coronary heart disease (CHD) through the enhancement of oxidative stress (<xref rid="B38" ref-type="bibr">38</xref>). Anti-oxidant defense system (SOD and GPx) protects plasma lipoproteins against oxidative stress (<xref rid="B39" ref-type="bibr">39</xref>). The elevation of ROS generation under stress conditions (diabetes and obesity) causes oxidative damage of lipoproteins in the plasma (<xref rid="B40" ref-type="bibr">40</xref>, <xref rid="B41" ref-type="bibr">41</xref>). The oxidation of lipoproteins increases TG, very-low-density lipoprotein (VLDL), low-density lipoprotein (LDL) concentrations in plasma (<xref rid="B40" ref-type="bibr">40</xref>). The measure of serum TG, total cholesterol (TC), LDL, HDL, and cholesterol is the reference procedure for the determination of lipid profile (<xref rid="B42" ref-type="bibr">42</xref>). As mentioned in <xref rid="T2" ref-type="table">Table 2</xref> several studies have been shown the effects of neem in the management of hyperlipidemia. </p><p>Different doses of neem (100, 200, 250, 300, 400, and 500 mg/kg) in streptozotocin (STZ)-diabetic rats decreased serum TC, TG, LDL, VLDL levels and increased serum HDL levels (<xref rid="B43" ref-type="bibr">43</xref>-<xref rid="B48" ref-type="bibr">48</xref>). Also, two different doses of neem (7.5 and 20 mg/kg) in STZ-diabetic mice normalized lipid profile (<xref rid="B49" ref-type="bibr">49</xref>, <xref rid="B50" ref-type="bibr">50</xref>). Neem (200, 250, 400, and 500 mg/kg, p.o.) reduced TC, TG, HDL, LDL, VLDL in rats which were treated with alloxan (120 mg/kg, i.p.) (<xref rid="B51" ref-type="bibr">51</xref>-<xref rid="B53" ref-type="bibr">53</xref>). Also, neem attenuated hyperglycemia, and hyperlipidemia via induction of SOD, catalase (CAT) levels in diabetic rats (<xref rid="B46" ref-type="bibr">46</xref>). The aqueous leaf extract of neem (250, 500, and 1000 mg/kg, p.o.) decreased TC and TG levels and increased HDL levels in rats which were treated with isoprenaline (<xref rid="B54" ref-type="bibr">54</xref>). The leaf extract of neem (50 and 300 mg/kg/day orally) prevented the rise of TC, LDL, and TG in cholesterol-fed rats (<xref rid="B55" ref-type="bibr">55</xref>). The mechanisms which are important in the effects of neem against hyperlipidemia have been shown in <xref ref-type="fig" rid="F2">Figure 2</xref>.</p><p>
<italic>Effects of neem on obesity</italic>
</p><p>Obesity and overweight are a serious health problem that is increasing worldwide. Obesity is associated with a life expectancy decrease and a significant increase in mortality (<xref rid="B56" ref-type="bibr">56</xref>). Stress, inadequate sleep, intake of alcohol, inactivity, unhealthy diet, age, genetic are some of the risk factors for obesity <xref ref-type="fig" rid="F2">Figure 2</xref> (<xref rid="B57" ref-type="bibr">57</xref>). Diabetes, heart disease, high blood pressure, hyperlipidemia, and atherosclerosis are obesity-related complications (<xref rid="B58" ref-type="bibr">58</xref>). Lipase and &#x003b1;-glucosidase are two types of obesity agents that use of their inhibitors can be the ideal therapy for obesity control (<xref rid="B59" ref-type="bibr">59</xref>, <xref rid="B60" ref-type="bibr">60</xref>).</p><p>The aqueous and methanolic extract of stem bark and roots of neem (520 &#x000b5;g/ml) inhibited pancreatic lipase and &#x003b1;- glucosidase in an <italic>in vitro</italic> system (<xref rid="B59" ref-type="bibr">59</xref>). But, the leaf extract of neem as a medicinal plant (500 mg/kg, orally) is not decreased the body weight in rats were treated for 28 days (<xref rid="B60" ref-type="bibr">60</xref>). There are a few studies available on the protective effects of neem against obesity which has been included in <xref rid="T3" ref-type="table">Table 3</xref>. Therefore, the effects of neem on obesity cannot be appropriately explained, and further studies are needed.</p><p>
<italic>Effects of neem on diabetes</italic>
</p><p>Diabetes, as a growing public health problem, is characterized by impairment of systemic insulin secretion, reduction of insulin action, and resulting in hyperglycemia (<xref rid="B61" ref-type="bibr">61</xref>). Diabetes-associated main complications are nerve damage (<xref rid="B62" ref-type="bibr">62</xref>), myocardial infarction (<xref rid="B63" ref-type="bibr">63</xref>), atherosclerosis (<xref rid="B64" ref-type="bibr">64</xref>), renal failure (<xref rid="B65" ref-type="bibr">65</xref>), blindness (<xref rid="B66" ref-type="bibr">66</xref>), and limb amputation (<xref rid="B67" ref-type="bibr">67</xref>). The microvascular disease has been known as the foremost cause of these complications (<xref rid="B68" ref-type="bibr">68</xref>). Glucose-mediated vascular damage occurs as a result of the overproduction of ROS and oxidative stress (<xref rid="B69" ref-type="bibr">69</xref>). Enzymatic and nonenzymatic anti-oxidants are defense mechanisms against oxidative stress. Common enzymatic anti-oxidants include SOD, CAT, GPx, and glutaredoxin (GRx). Vitamins A, C, E, and glutathione are common nonenzymatic anti-oxidants (<xref rid="B70" ref-type="bibr">70</xref>). Pancreatic beta cells are more susceptible to oxidative stress than other cells because they have relatively low levels of anti-oxidants (<xref rid="B71" ref-type="bibr">71</xref>). Therefore, the reduction of ROS and induction of anti-oxidant activity are therapeutic approaches to decrease hyperglycemia and diabetes (<xref rid="B72" ref-type="bibr">72</xref>). On the other hand, salivary &#x003b1;-amylase and intestinal glucosidases play an essential role in the digestion of starch to produce glucose in the small intestine (<xref rid="B73" ref-type="bibr">73</xref>). Also, the inhibition of these enzymes could be effective in the control of diabetes (<xref rid="B74" ref-type="bibr">74</xref>). Several reports have been shown that medicinal plants useful for the management and treatment of diabetes. Some of these plants include<italic> Vernonia amygdalina (</italic><xref rid="B75" ref-type="bibr">75</xref><italic>)</italic>, <italic>Nigella</italic>
<italic>sativa</italic> L. (<xref rid="B76" ref-type="bibr">76</xref>), grapes (<italic>Vitis vinifera</italic>) (<xref rid="B77" ref-type="bibr">77</xref>), and<italic> Allium sativum </italic>(garlic) (<xref rid="B78" ref-type="bibr">78</xref>) which are useful in the remedy of diabetes. The use of the neem is most popular to control diabetes in different regions of the world, such as India (<xref rid="B79" ref-type="bibr">79</xref>), Pakistan (<xref rid="B80" ref-type="bibr">80</xref>), Bengal (<xref rid="B81" ref-type="bibr">81</xref>), Indonesia (<xref rid="B82" ref-type="bibr">82</xref>), and Northwest Nigeria (<xref rid="B83" ref-type="bibr">83</xref>). Glucagon-like peptide-1 (GLP-1) is a hormone that plays an essential role in the release of insulin and is inactivated by dipeptidyl peptidase IV (DPP-IV) (<xref rid="B84" ref-type="bibr">84</xref>, <xref rid="B85" ref-type="bibr">85</xref>). Inhibition of DPP-IV (a peptidase) is a method for diabetes treatment (<xref rid="B86" ref-type="bibr">86</xref>). In this method, substrate Gly-Pro-p-Nitroanilide (GPPN) was cleaved to paranitroanilide (a yellow-colored product) by DPP-IV and the absorbance was measured at 380 nm. Inhibitory activity of neem leaves (35 &#x003bc;l with varying concentrations) was determined on DPP-IV activity via this method, and neem exhibited a weak inhibitory activity (17%) on DPP-IV (<xref rid="B82" ref-type="bibr">82</xref>).</p><p>
<italic>&#x02022; Effects of neem in diabetic human</italic>
</p><p>Neem is available as a dietary supplement in an herbal mixture in North America. Treatment with this dietary supplement (2 capsules 3 times per day) for 3 months in type 2 diabetic patients (the ages of 18 and 70) improved glucose control and HbA1c levels (<xref rid="B87" ref-type="bibr">87</xref>). The study of Kochhar has been investigated the antidiabetic effect of neem in 90 diabetic men 40 to 60 years of age. Subjects received 2 g of neem leaf powder daily for three months. The results of this study showed that neem reduces sweating, headache, burning feet, itching, polydipsia, and polyphagia in diabetic humans (<xref rid="B34" ref-type="bibr">34</xref>).</p><p>
<italic>&#x02022; Effects of neem in alloxan/streptozotocin-induced diabetic animals</italic>
</p><p>
<italic>&#x02022;&#x02022; Effects of neem in alloxan-induced diabetic rats</italic>
</p><p>Alloxan is a toxic glucose analog that accumulates in pancreatic beta cells via glucose transporter 2 (GLUT2) and inhibits its function. The intraperitoneal injection of alloxan (at doses of 100, 120, and 150 mg/kg) is a conventional method for the induction of diabetes in rat models (<xref rid="B88" ref-type="bibr">88</xref>). The oral administration of ethanolic extract of neem in different doses (100 to 800 mg/kg for 14 or 28 days) reduced blood glucose levels in rats which were treated with alloxan (<xref rid="B52" ref-type="bibr">52</xref>, <xref rid="B89" ref-type="bibr">89</xref>, <xref rid="B90" ref-type="bibr">90</xref>). The combination of neem (50 mg/kg) with <italic>Gynura procumbens</italic> ethanolic (112.5 mg/kg) extracts (2 times a day for 15 days) increased insulin expression, decreased blood glucose concentration, and improved the morphology of the islets of Langerhans and beta-cells in rats (<xref rid="B91" ref-type="bibr">91</xref>). The aqueous extract of neem leaf and bark was effective in reducing oxidative stress markers and lipid peroxidation of the blood sample, liver, and kidney tissues in diabetic rats (<xref rid="B92" ref-type="bibr">92</xref>, <xref rid="B93" ref-type="bibr">93</xref>). Polyherbal formulation (PHF) is containing more than one herb that is used all around the world to treat diseases (<xref rid="B94" ref-type="bibr">94</xref>). PHFs used in the treatment of diabetes are including Karnim Plus and DIA7. The antidiabetic activity of Karnim Plus and DIA7 is investigated in rats treated with alloxan. Karnim Plus and DIA7 contain neem extract and decrease blood glucose levels in diabetic rats (<xref rid="B51" ref-type="bibr">51</xref>, <xref rid="B95" ref-type="bibr">95</xref>). In <xref rid="T4" ref-type="table">Table 4</xref>, different studies on the effect of neem on diabetes have been summarized. </p><p>
<italic>&#x02022;&#x02022; Effects of neem in alloxan-induced diabetic rabbits</italic>
</p><p>The hypoglycemic effect of neem (ethanolic extract of leaves, 200 mg/kg) was observed in rabbits that were treated with alloxan (150 mg/kg, i.v.) (<xref rid="B96" ref-type="bibr">96</xref>). Also, leaf extract (500 mg/kg, p.o. daily for six weeks) and seed oil (5 mg/kg, p.o. daily for six weeks) of neem decreased blood glucose in diabetic rabbits (alloxan in a single dose, 140 mg/kg, i.v.) (<xref rid="B97" ref-type="bibr">97</xref>).</p><p>
<italic>&#x02022;&#x02022; Effects of neem in streptozotocin-induced diabetic rats</italic>
</p><p>Streptozotocin (STZ) is one of the most diabetogenic agents using in diabetes research. Its mechanisms for the induction of diabetes are inhibition of insulin secretion and the death of the beta-cells (<xref rid="B88" ref-type="bibr">88</xref>). In rat models, the injection of STZ (at doses of 35, 45, 55, 60, 65, 70, and 100 mg/kg) is a standard method for the induction of diabetes (<xref rid="B47" ref-type="bibr">47</xref>, <xref rid="B48" ref-type="bibr">48</xref>, <xref rid="B98" ref-type="bibr">98</xref>-<xref rid="B102" ref-type="bibr">102</xref>). The ethanolic extract of neem leaves (at doses of 200 and 500 mg/kg, p.o.) reduced blood glucose levels in rats were treated with STZ (<xref rid="B44" ref-type="bibr">44</xref>). Moreover, the oral administration of neem (leaf ethanolic extract) induced markers of the anti-oxidant system (SOD, CAT, GPx, and GSH levels) and reduced lipid peroxidation in diabetic rats (<xref rid="B103" ref-type="bibr">103</xref>) (<xref ref-type="fig" rid="F3">Figure 3</xref>). The aqueous extract of neem leaves (at doses of 100, 200, 250, 400, 500 and 600 mg/kg, p.o.) decreased blood glucose levels and improved serum insulin levels in rats were treated with STZ (<xref rid="B45" ref-type="bibr">45</xref>, <xref rid="B47" ref-type="bibr">47</xref>, <xref rid="B100" ref-type="bibr">100</xref>, <xref rid="B101" ref-type="bibr">101</xref>, <xref rid="B104" ref-type="bibr">104</xref>, <xref rid="B105" ref-type="bibr">105</xref>). Moreover, neem (400 mg/kg, p.o. for 30 days) increased insulin receptor protein expression in diabetic rats (STZ: 35 mg/kg, i.p.). It also up-regulated cytosolic and plasma membrane glucose transporter 4 (GLUT4) in the gastrocnemius muscle of diabetic rats (<xref rid="B47" ref-type="bibr">47</xref>). Insulin enhances glucose uptake into muscle tissues through GLUT4, and therefore it controls glucose homeostasis (<xref rid="B106" ref-type="bibr">106</xref>). Several studies investigated the effects of PHFs on diabetes in rats which were treated with STZ. Allopolyherbal (neem at the dose of 500 mg/kg) (<xref rid="B107" ref-type="bibr">107</xref>), Glucova Active (<xref rid="B43" ref-type="bibr">43</xref>), Dihar (10 % of neem) (<xref rid="B108" ref-type="bibr">108</xref>), MAC-ST/001 (20 g/100 g of neem) (<xref rid="B109" ref-type="bibr">109</xref>), and Herbo-mineral (25 mg of neem) (<xref rid="B109" ref-type="bibr">109</xref>) are PHFs that decrease blood glucose levels and increase insulin level in STZ-diabetic&#x000a0;rat<italic>.</italic></p><p>
<italic>&#x02022;&#x02022; Effects of neem in streptozotocin-induced diabetic mice</italic>
</p><p>The decrease of serum glucose levels and increase of glycogen content, plasma insulin, and c-peptide levels with aqueous extract of neem have been shown in mice treated with STZ (<xref rid="B110" ref-type="bibr">110</xref>, <xref rid="B111" ref-type="bibr">111</xref>). Also, the increase of glucose-6-phosphate dehydrogenase (G6PD) activity with neem has been shown in diabetic mice (<xref rid="B110" ref-type="bibr">110</xref>). The chloroform extract of neem in addition to reducing glucose level and induction of insulin level decreased oxidative stress markers and LPO in mice treated with STZ-nicotinamide. Also, it reduced glucose-6-phosphatase-&#x003b1; (G6Pase), glucokinase (GK), &#x003b1;-amylase, and &#x003b1;-glucosidase activities, and induced HK activity (<xref rid="B50" ref-type="bibr">50</xref>). Dianex, an herbal formulation is containing neem at a dose of 7.5 mg/kg. Dianex has been shown hypoglycemic effects in STZ-diabetic mice (<xref rid="B49" ref-type="bibr">49</xref>).</p><p>
<italic>&#x02022; Effects of neem in glucose-induced diabetic animals</italic>
</p><p>The aqueous and ethanolic extracts of neem leaves decreased glucose level and increased insulin secretion in rats were treated with glucose (3 mg/ml, p.o.) (<xref rid="B112" ref-type="bibr">112</xref>, <xref rid="B113" ref-type="bibr">113</xref>). Also, the potential use of ethanolic extract rhizome of neem (300 mg/kg, p.o.) was investigated in mice that were treated with glucose (1 g/kg). In this study, neem reduced blood glucose (<xref rid="B114" ref-type="bibr">114</xref>).</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Main mechanisms of neem on high blood pressure. Mechanisms underlying the protective effect of neem against high BP are including the block of calcium channels, up-regulation of ERK 1/2 and Nrf2 gene expression, and normalize serum of NO bioavailability. ARE: Anti-oxidant response element; eNOS: endothelial nitric oxide synthase; ERKs: extracellular-regulated kinases; GPX: glutathione peroxidase; GST: glutathione S-transferases, Nrf2: nuclear factor erythroid-2-related factor 2; NO: nitric oxide; ROS: reactive oxygen species; SOD: superoxide dismutase</p></caption><graphic xlink:href="IJBMS-24-280-g001"/></fig><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Effects of neem against high blood pressure</p></caption><table frame="hsides" rules="groups"><thead><tr><th style=" color:#000000;" align="left" valign="middle" rowspan="1" colspan="1">Part (s) of the plant used/ Extract(s)</th><th align="left" valign="middle" rowspan="1" colspan="1">Neem dose/ route</th><th style=" color:#2F5496;" align="left" valign="middle" rowspan="1" colspan="1">Study design</th><th align="left" valign="middle" rowspan="1" colspan="1">Results</th><th style=" color:#000000;" align="center" valign="middle" rowspan="1" colspan="1">Ref</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leaves/ methanolic</td><td align="left" valign="middle" rowspan="1" colspan="1">100 and 200 (mg/kg), p.o.</td><td style=" color:#2F5496;" align="left" valign="middle" rowspan="1" colspan="1">Male rats, L-NAM<break/>(40 mg/kg), p.o.</td><td style=" color:#2F5496;" align="left" valign="middle" rowspan="1" colspan="1">&#x02193; BP<break/>&#x02191; NO level<break/>&#x02193;Oxidative stress<break/>&#x02191;Expressions of Nrf2</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B32" ref-type="bibr">32</xref>, <xref rid="B115" ref-type="bibr">115</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leaves/ methanolic</td><td align="left" valign="middle" rowspan="1" colspan="1">100 and 200(mg/kg), p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Male rats, NaF 600 (ppm)</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193; BP<break/>&#x02193;Oxidative stress<break/>&#x02191; Expressions of ERK</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B116" ref-type="bibr">116</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Crude/ aqueous</td><td style=" color:#2F5496;" align="left" valign="middle" rowspan="1" colspan="1">1, 3, 10 and 30 (mg/kg), p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Male and female rats, arterial cannula</td><td style=" color:#2F5496;" align="left" valign="middle" rowspan="1" colspan="1">&#x02193; BP<break/>Blockade Ca<sup>++</sup> channel<break/>&#x02191; NO</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B30" ref-type="bibr">30</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Crude/ aqueous and ethylacetate</td><td style=" color:#2F5496;" align="left" valign="middle" rowspan="1" colspan="1">0.01- 10 mg/ml, p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Rabbit, isolated rabbit aorta</td><td style=" color:#2F5496;" align="left" valign="middle" rowspan="1" colspan="1">&#x02193; BP<break/>Blockade Ca<sup>++</sup> channel<break/>&#x02191; NO</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B30" ref-type="bibr">30</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Crude/ aqueous and ethylacetate</td><td align="left" valign="middle" rowspan="1" colspan="1">0.001- 10 mg/ml, p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Rats, isolated rat aorta</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193; BP<break/>Blockade Ca<sup>++</sup> channel<break/>&#x02191; NO</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B30" ref-type="bibr">30</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Crude/ aqueous and ethylacetate</td><td align="left" valign="middle" rowspan="1" colspan="1">0.01- 10 mg/ml, p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Guinea pig, isolated guinea pig atrial</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193; BP<break/>Blockade Ca<sup>++</sup> channel<break/>&#x02191; NO</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B30" ref-type="bibr">30</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leaves/ aqueous</td><td align="left" valign="middle" rowspan="1" colspan="1">20 (mg/kg), p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Male rats, DOCA-salt 15 (mg/kg), s.c.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193; MAP<break/>&#x02193; Alterations of ECG</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B33" ref-type="bibr">33</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leaves/ alcoholic</td><td align="left" valign="middle" rowspan="1" colspan="1">100, 300 and 1000, (mg/kg), i.v.</td><td align="left" valign="middle" rowspan="1" colspan="1">Male rats, atropine (1mg/kg) and mepyramine (3 mg/kg), i.v.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193; BP</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B117" ref-type="bibr">117</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leaves</td><td align="left" valign="middle" rowspan="1" colspan="1">5, 10, 20, 40, 80, 100, and 200, (mg/kg), i.v.</td><td align="left" valign="middle" rowspan="1" colspan="1">Rabbit and guinea pig, ouabain-induced cardiac dysrhythmias</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193; BP</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B118" ref-type="bibr">118</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leaves/ aqueous</td><td align="left" valign="middle" rowspan="1" colspan="1">2 g, p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Male patients<break/>(40-60 years)</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193; BP</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B34" ref-type="bibr">34</xref>)</td></tr></tbody></table><table-wrap-foot><p>&#x02191;: increase; &#x02193;: decrease; BP: blood pressure; DOCA: deoxycorticosterone acetate; ECG: electrocardiogram; ERK: extracellular signal-regulated kinase; g: gram; i.v.: intravenous; kg: kilogram; L-NAM: N &#x003c9; -nitro-L-arginine methyl ester; MAP: mitogen-activated protein; mg: milligram; NO: nitric oxide; Nrf2: Nuclear factor erythroid 2&#x02013;related factor 2; p.o.: per os (orally); ppm: parts per million; s.c.: subcutaneous</p></table-wrap-foot></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Effects of neem against hyperlipidemia</p></caption><table frame="hsides" rules="groups"><thead><tr><th style=" color:#000000;" align="left" valign="middle" rowspan="1" colspan="1">
<bold>Part (s) of the plant used/ Extract(s)</bold>
</th><th align="left" valign="middle" rowspan="1" colspan="1">
<bold>Neem dose/ route</bold>
</th><th style=" color:#2F5496;" align="left" valign="middle" rowspan="1" colspan="1">
<bold>Study design</bold>
</th><th align="left" valign="middle" rowspan="1" colspan="1">
<bold>Results</bold>
</th><th style=" color:#000000;" align="center" valign="middle" rowspan="1" colspan="1">
<bold>Ref</bold>
</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leaves/ aqueous</td><td align="left" valign="middle" rowspan="1" colspan="1">250 mg/kg, p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Male and female rats, <break/>STZ (60 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193; LDL, TG, and cholesterol<break/> &#x02191; HDL</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B45" ref-type="bibr">45</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leaves/ aqueous</td><td align="left" valign="middle" rowspan="1" colspan="1">400 mg/kg, p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Male rats, <break/>STZ (35 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">Normalized lipid profile</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B47" ref-type="bibr">47</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leaves/ aqueous</td><td align="left" valign="middle" rowspan="1" colspan="1">500 mg/kg, p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Rats, <break/>STZ (45 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193; Cholesterol, TG</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B48" ref-type="bibr">48</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leaves/ chloroform</td><td align="left" valign="middle" rowspan="1" colspan="1">300 mg/kg, p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Male rats, <break/>STZ (60 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193; LPO, &#x02191;SOD, CAT activity, &#x02191; GSH levels, &#x02193; GSSG levels</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B46" ref-type="bibr">46</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leaves/ alcoholic</td><td align="left" valign="middle" rowspan="1" colspan="1">200 mg/kg, p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Male rats,<break/> STZ (50 mg/kg), i.v.</td><td style=" color:#000000;" align="left" valign="middle" rowspan="1" colspan="1">&#x02193;TC, &#x02193; TG, LDL and VLDL</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B44" ref-type="bibr">44</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Seeds/ petroleum ether</td><td align="left" valign="middle" rowspan="1" colspan="1">0.09 and 2 mg/kg, p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Male rats, <break/>STZ (55 mg/kg), i.v.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;TC, TG</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B119" ref-type="bibr">119</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Allopolyherbal</td><td align="left" valign="middle" rowspan="1" colspan="1">500 mg/kg, p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Male and female rats, <break/>STZ (60 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193; TC, TG, LDL, VLDL, serum creatinine, SGOT, and SGPT<break/>&#x02191; HDL</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B107" ref-type="bibr">107</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Glucova Active</td><td align="left" valign="middle" rowspan="1" colspan="1">_</td><td align="left" valign="middle" rowspan="1" colspan="1">Rats, <break/>STZ (35 and 50 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193; Serum cholesterol, TG, LDL, VLDL<break/>&#x02191; HDL</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B43" ref-type="bibr">43</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Dihar</td><td align="left" valign="middle" rowspan="1" colspan="1">10%, p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Male rats, <break/>STZ (45 mg/kg), i.v.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193; Cholesterol, TG, LDL, Creatinine, Urea and LPO<break/>&#x02191; HDL, SOD and CAT</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B108" ref-type="bibr">108</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leaves/ chloroform</td><td align="left" valign="middle" rowspan="1" colspan="1">20 mg/kg, p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Male mice, <break/>STZ (60 mg/kg), i.v.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193; TG, TC, &#x02191; HDL<break/>&#x02193; LPO</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B50" ref-type="bibr">50</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Dianex</td><td align="left" valign="middle" rowspan="1" colspan="1">7.5 mg/kg, p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Male and female mice, <break/>STZ (60 mg/kg), i.p.</td><td style=" color:#000000;" align="left" valign="middle" rowspan="1" colspan="1">&#x02193; TG, cholesterol, urea and cratininine</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B49" ref-type="bibr">49</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leaves/ methanolic</td><td align="left" valign="middle" rowspan="1" colspan="1">500 mg/kg, p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Male and female rats,<break/> alloxan (100 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02191; HDL<break/>&#x02193; LDL and TG</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B53" ref-type="bibr">53</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leaves/ ethanolic</td><td align="left" valign="middle" rowspan="1" colspan="1">100 and 250 mg/kg, p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Male rats, <break/>alloxan (120 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193; TC, TG, HDL, LDL, VLDL</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B52" ref-type="bibr">52</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leaves/ ethanolic</td><td align="left" valign="middle" rowspan="1" colspan="1">100 mg/kg, p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Male rats, <break/>alloxan (120 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193; Serum cholesterol, TG, LDL, creatinine, and urea<break/> &#x02191; HDL</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B89" ref-type="bibr">89</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Karnim Plus</td><td align="left" valign="middle" rowspan="1" colspan="1">200 and 400 mg/kg, p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Rats, <break/>alloxan (120 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193; Serum cholesterol, TG, creatinine, and urea</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B51" ref-type="bibr">51</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Ethanolic (leaves)</td><td align="left" valign="middle" rowspan="1" colspan="1">50 and 300 mg/kg, p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Male rats, <break/>cholesterol</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;TC, LDL and TG</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B55" ref-type="bibr">55</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Aqueous (leaves)</td><td align="left" valign="middle" rowspan="1" colspan="1">250, 500 and 1000 mg/kg, p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Male rats,<break/> isoprenaline (25 mg/kg), s.c.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;TC and TG<break/>&#x02191; HDL</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B54" ref-type="bibr">54</xref>)</td></tr></tbody></table><table-wrap-foot><p>&#x02191;: increase; &#x02193;: decrease; CAT: catalase; GSH: glutathione; GSSG: glutathione disulfide; HDL: high-density lipoprotein; i.p.: intraperitoneal; i.v.: intravenous, kg: kilogram; LDL: low-density lipoprotein; LPO: lipid peroxidation; mg: milligram; p.o.: per os (orally); SGOT: serum glutamic oxaloacetic transaminase; SGPT: serum glutamic pyruvic transaminase, SOD: superoxide dismutase; STZ: streptozotocin; TC: total cholesterol; TG: triglyceride; VLDL: very-low-density lipoprotein</p></table-wrap-foot></table-wrap><fig id="F2" position="float"><label>Figure 2</label><caption><p>Main mechanisms of neem on hyperlipidemia. Neem has been shown protective effects against hyperlipidemia via improvement of the function of anti-oxidant markers and inhibition of oxidative damage of lipoproteins</p></caption><graphic xlink:href="IJBMS-24-280-g002"/><p>HDL: high-density lipoprotein; LDL: low-density lipoprotein; ROS: reactive oxygen species; TC: total cholesterol; TG: triglyceride; VLDL: very-low-density lipoprotein</p></fig><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Effects of neem against obesity</p></caption><table frame="hsides" rules="groups"><thead><tr><th style=" color:#000000;" align="left" valign="middle" rowspan="1" colspan="1">
<bold>Part (s) of the plant used/ Extract(s)</bold>
</th><th align="left" valign="middle" rowspan="1" colspan="1">
<bold>Neem dose/ route</bold>
</th><th style=" color:#2F5496;" align="left" valign="middle" rowspan="1" colspan="1">
<bold>Study design</bold>
</th><th align="left" valign="middle" rowspan="1" colspan="1">
<bold>Results</bold>
</th><th style=" color:#000000;" align="center" valign="middle" rowspan="1" colspan="1">
<bold>Ref</bold>
</th></tr></thead><tbody><tr><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Leaves/ aqueous</td><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">500 mg/kg, p.o.</td><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Male and female rats</td><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">No effect</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B60" ref-type="bibr">60</xref>)</td></tr><tr><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Stem-bark and roots/ aqueous and methanolic</td><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">IC50: 520 &#x000b5;g/ml</td><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">
<italic>In vitro</italic>
</td><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Inhibited pancreatic lipase and &#x003b1;- glucosidase</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B59" ref-type="bibr">59</xref>)</td></tr></tbody></table><table-wrap-foot><p>IC50: inhibitory concentration; kg: kilogram; &#x000b5;g: microgram; mg: milligram; ml: milliliter; p.o.: per os (orally)</p></table-wrap-foot></table-wrap><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>Effects of neem against diabetes</p></caption><table frame="hsides" rules="groups"><thead><tr><th style=" color:#000000;" align="left" valign="middle" rowspan="1" colspan="1">
<bold>Part (s) of the plant used/ Extract (s)</bold>
</th><th align="left" valign="middle" rowspan="1" colspan="1">
<bold>Neem dose/ route</bold>
</th><th style=" color:#2F5496;" align="left" valign="middle" rowspan="1" colspan="1">
<bold>Study design</bold>
</th><th align="left" valign="middle" rowspan="1" colspan="1">
<bold>Results</bold>
</th><th style=" color:#000000;" align="center" valign="middle" rowspan="1" colspan="1">
<bold>Ref</bold>
</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Bark root/ ethanolic </td><td align="left" valign="middle" rowspan="1" colspan="1">200, 400, 800 mg/kg, p.o.</td><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Rats, alloxan (100 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B90" ref-type="bibr">90</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leaves and seeds/ ethanolic</td><td align="left" valign="middle" rowspan="1" colspan="1">500 mg/kg, p.o.</td><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Males rats, alloxan (120 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B120" ref-type="bibr">120</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leaves/ ethanolic</td><td align="left" valign="middle" rowspan="1" colspan="1">200 mg/kg, p.o.</td><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Rats, alloxan (150 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B121" ref-type="bibr">121</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leaves/ ethanolic</td><td align="left" valign="middle" rowspan="1" colspan="1">100 and 250 mg/kg, p.o.</td><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Males rats, alloxan (120 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B52" ref-type="bibr">52</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leaves/ ethanolic</td><td align="left" valign="middle" rowspan="1" colspan="1">250 mg/kg, p.o.</td><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Males rats, alloxan (100 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B122" ref-type="bibr">122</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leaves/ ethanolic</td><td align="left" valign="middle" rowspan="1" colspan="1">100 mg/kg, p.o.</td><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Males rats, alloxan (120 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B89" ref-type="bibr">89</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leaves/ ethanolic</td><td align="left" valign="middle" rowspan="1" colspan="1">200 mg/kg, p.o.</td><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Males rats, alloxan (150 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG, &#x02191;Insulin<break/>Protected beta cells and islets Langerhans</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B91" ref-type="bibr">91</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leaves and bark/ aqueous</td><td align="left" valign="middle" rowspan="1" colspan="1">100 and 500 mg/kg, p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Rats, alloxan (150 mg/kg), s.c.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG<break/>&#x02193; Oxidative stress markers and LPO and DNA fragmentation and PKC beta II</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B92" ref-type="bibr">92</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leaves and bark/ aqueous</td><td align="left" valign="middle" rowspan="1" colspan="1">100 and 500 mg/kg, p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Rats, alloxan</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG<break/>&#x02193; Oxidative stress markers and LPO</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B93" ref-type="bibr">93</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leaves and bark/ aqueous</td><td align="left" valign="middle" rowspan="1" colspan="1">75 mg/kg, p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Rats, alloxan (150 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B123" ref-type="bibr">123</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leaves/ aqueous</td><td align="left" valign="middle" rowspan="1" colspan="1">25, 50 and 100 mg/kg, p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Rats, alloxan (150 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG<break/>&#x02193; Oxidative stress markers and LPO</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B124" ref-type="bibr">124</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leaves/ aqueous</td><td align="left" valign="middle" rowspan="1" colspan="1">400 mg/kg, p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Males and females rats, alloxan (150 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG<break/>Improved liver function</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B125" ref-type="bibr">125</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Seeds/ aqueous</td><td align="left" valign="middle" rowspan="1" colspan="1">500 mg/kg, p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Males and females rats, alloxan (150 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B126" ref-type="bibr">126</xref>)</td></tr><tr><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Leaves/ polyherbal </td><td align="left" valign="middle" rowspan="1" colspan="1">200 and 400 mg/kg, p.o.</td><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Rats, alloxan (120 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B51" ref-type="bibr">51</xref>)</td></tr><tr><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Leaves/ polyherbal</td><td align="left" valign="middle" rowspan="1" colspan="1">14.28%</td><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Rats, alloxan (150 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B95" ref-type="bibr">95</xref>)</td></tr><tr><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Leaves/ ethanolic</td><td align="left" valign="middle" rowspan="1" colspan="1">200 g, p.o.</td><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Rabbits, alloxan (150 mg/kg), i.v.</td><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B96" ref-type="bibr">96</xref>)</td></tr><tr><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Leaves/ aqueous</td><td align="left" valign="middle" rowspan="1" colspan="1">500 ml/kg, p.o.</td><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Males and female rabbits, alloxan</td><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B97" ref-type="bibr">97</xref>)</td></tr><tr><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Seeds/ aqueous</td><td align="left" valign="middle" rowspan="1" colspan="1">5 mg/kg, p.o.</td><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Males and females rabbits, alloxan</td><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B97" ref-type="bibr">97</xref>)</td></tr><tr><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Leaves/ chloroform</td><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">200 mg/kg, p.o.</td><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Males rats, STZ (50 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG, &#x02193; LPO<break/>&#x02191; Antioxidant markers</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B104" ref-type="bibr">104</xref>)</td></tr><tr><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Leaves/ chloroform</td><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">300 mg/kg, p.o.</td><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Males rats, STZ (65 mg/kg), i.v.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG, &#x02191; Insulin<break/>&#x02191; Antioxidant markers<break/>&#x02193; LPO</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B46" ref-type="bibr">46</xref>)</td></tr><tr><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Leaves/ aqueous</td><td align="left" valign="middle" rowspan="1" colspan="1">600 mg/kg, p.o.</td><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Males rats, STZ (60 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG, &#x02193; LPO<break/>&#x02191; Antioxidant markers<break/>protected beta cells and islets langerhans<break/>&#x02191; Pain threshold</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B99" ref-type="bibr">99</xref>)</td></tr><tr><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Leaves/ aqueous</td><td align="left" valign="middle" rowspan="1" colspan="1">600 mg/kg, p.o.</td><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Males rats, STZ (60 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG, &#x02193; LPO<break/>&#x02191; Antioxidant markers<break/>protected beta cells and islets langerhans</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B105" ref-type="bibr">105</xref>)</td></tr><tr><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Leaves/ aqueous</td><td align="left" valign="middle" rowspan="1" colspan="1">400 mg/kg, p.o.</td><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Males rat, STZ (35 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG, &#x02191; Insulin<break/>Normalized GluT4</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B47" ref-type="bibr">47</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leaves/ aqueous</td><td align="left" valign="middle" rowspan="1" colspan="1">500 mg/kg, p.o.</td><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Rats, STZ (45 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG, &#x02193; LPO<break/>&#x02191; Antioxidant markers<break/>protected beta cells and islets langerhans</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B48" ref-type="bibr">48</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leaves/ aqueous</td><td align="left" valign="middle" rowspan="1" colspan="1">500 mg/kg, p.o.</td><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Males and females rat, STZ (55 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG, &#x02193; LPO<break/>&#x02191; Antioxidant markers</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B98" ref-type="bibr">98</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leaves/ aqueous</td><td align="left" valign="middle" rowspan="1" colspan="1">250 mg/kg, p.o.</td><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Males rat, STZ (60 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B45" ref-type="bibr">45</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leaves/ aqueous</td><td align="left" valign="middle" rowspan="1" colspan="1">100 mg/kg, p.o.</td><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Males rat, STZ (65 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B100" ref-type="bibr">100</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leaves/ aqueous</td><td align="left" valign="middle" rowspan="1" colspan="1">10 ml/kg, p.o.</td><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Males rat, STZ (65 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG, &#x02193; LPO<break/>&#x02191; Antioxidant markers</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B127" ref-type="bibr">127</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leaves/ aqueous</td><td align="left" valign="middle" rowspan="1" colspan="1">50, 100, 200 and 400 mg/kg, p.o.</td><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Males and females rat, STZ (50 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG<break/>&#x02191; Antioxidant markers<break/>&#x02193; LPO</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B128" ref-type="bibr">128</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leaves/ ethanolic</td><td align="left" valign="middle" rowspan="1" colspan="1">200 mg/kg, p.o.</td><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Males rat, STZ (65 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B103" ref-type="bibr">103</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leaves/ ethanolic</td><td align="left" valign="middle" rowspan="1" colspan="1">200 mg/kg, p.o.</td><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Males rat, STZ (50 mg/kg), i.v.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG, &#x02193; LPO<break/>&#x02191; Antioxidant markers</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B44" ref-type="bibr">44</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leaves/ ethanolic</td><td align="left" valign="middle" rowspan="1" colspan="1">500 mg/kg, p.o.</td><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Males and females rat, STZ (70 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG, &#x02193; LPO<break/>&#x02191; Antioxidant markers<break/>protected beta cells and islets langerhans</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B101" ref-type="bibr">101</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leaves/ ethanolic</td><td align="left" valign="middle" rowspan="1" colspan="1">500 mg/kg, p.o.</td><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Males rat, STZ (70 mg/kg), i.v.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG, &#x02193; LPO<break/>&#x02191; Antioxidant markers</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B129" ref-type="bibr">129</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leaves/ ethanolic</td><td align="left" valign="middle" rowspan="1" colspan="1">500 mg/kg, p.o.</td><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Males rat, STZ (70 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG<break/>protected beta cells and islets langerhans</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B130" ref-type="bibr">130</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Seeds / ethanolic</td><td align="left" valign="middle" rowspan="1" colspan="1">1.2 ml, p.o.</td><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Females rat, STZ (100 mg/kg), s.c.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG, &#x02193; LPO<break/>&#x02191; Antioxidant markers</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B102" ref-type="bibr">102</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leaves/ ethanolic</td><td align="left" valign="middle" rowspan="1" colspan="1">200 mg/kg, p.o.</td><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Males rat, STZ (65 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG, &#x02193; LPO<break/>&#x02191; Antioxidant markers</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B103" ref-type="bibr">103</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leaves/ ethanolic</td><td align="left" valign="middle" rowspan="1" colspan="1">500 mg/kg, p.o.</td><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Males and females rat, STZ (70 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B128" ref-type="bibr">128</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Seeds/ petroleum ether</td><td align="left" valign="middle" rowspan="1" colspan="1">0.9 and 2 mg/kg, p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Males rat, STZ (55 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG, &#x02193; LPO<break/>&#x02191; Antioxidant markers</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B131" ref-type="bibr">131</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Allopolyherbal</td><td align="left" valign="middle" rowspan="1" colspan="1">500 mg/kg, p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Males and females rat, STZ (60 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG, &#x02191; Insulin</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B107" ref-type="bibr">107</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Glucova Active</td><td align="left" valign="middle" rowspan="1" colspan="1">_</td><td align="left" valign="middle" rowspan="1" colspan="1">Rat, STZ (35 and 50 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG, &#x02191; Insulin<break/>protected beta cells</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B43" ref-type="bibr">43</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Dihar</td><td align="left" valign="middle" rowspan="1" colspan="1">10%, p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Males rat, STZ (45 mg/kg), i.v.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG, &#x02191; Insulin<break/>protected beta cells</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B108" ref-type="bibr">108</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MAC-ST/001</td><td align="left" valign="middle" rowspan="1" colspan="1">20 g/100 g, p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Males and females rat, STZ (55 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG, &#x02191; Insulin<break/>protected beta cells<break/>&#x02193; G6Pase</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B109" ref-type="bibr">109</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Herbo-mineral</td><td align="left" valign="middle" rowspan="1" colspan="1">25 mg/kg, p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Males rat, STZ (60 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG, &#x02191; Insulin</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B132" ref-type="bibr">132</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">_</td><td align="left" valign="middle" rowspan="1" colspan="1">100 g, p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Females rat, STZ (65 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG, &#x02191; Insulin<break/>protected beta cells<break/>&#x02193; G6Pase</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B133" ref-type="bibr">133</xref>)</td></tr><tr><td align="justify" valign="middle" rowspan="1" colspan="1">Leaves/ aqueous</td><td align="left" valign="middle" rowspan="1" colspan="1">100 &#x003bc;g/ 200 &#x003bc;L, p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Mice, STZ (3 mg/25 g), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG, &#x02193; G6Pase</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B110" ref-type="bibr">110</xref>)</td></tr><tr><td align="justify" valign="middle" rowspan="1" colspan="1">Seeds/ aqueous</td><td align="left" valign="middle" rowspan="1" colspan="1">1mg/ml, p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Females mice, STZ (100 mg/kg), s.c.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B102" ref-type="bibr">102</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leaves and seeds/ aqueous</td><td align="left" valign="middle" rowspan="1" colspan="1">100, 200, 300 &#x000b5;l, p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Males mice, STZ (55 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG<break/>&#x02191; Antioxidant markers</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B111" ref-type="bibr">111</xref>)</td></tr><tr><td align="justify" valign="middle" rowspan="1" colspan="1">Leaves/ chloroform</td><td align="justify" valign="middle" rowspan="1" colspan="1">20 and 30 mg/kg, p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Males mice, STZ (60-120 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG, &#x02191; Insulin<break/>&#x02191; Antioxidant markers<break/>&#x02193; LPO, G6Pase, GK, &#x003b1;-amylase and &#x003b1;-glucosidase activity <break/>&#x02191; HK activity</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B50" ref-type="bibr">50</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Dianex</td><td align="left" valign="middle" rowspan="1" colspan="1">7.5 mg/kg, p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Males and females mice, STZ (60 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B49" ref-type="bibr">49</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leaves/ aqueous</td><td align="left" valign="middle" rowspan="1" colspan="1">200 mg/kg, p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Males rabbit, STZ (50 mg/kg), i.p.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG, &#x02191;Insulin</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B113" ref-type="bibr">113</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leaves/ aqueous</td><td align="left" valign="middle" rowspan="1" colspan="1">400 mg/kg, p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Males and females rat, glucose (3 g/kg), p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B112" ref-type="bibr">112</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leaves/ ethanolic</td><td align="left" valign="middle" rowspan="1" colspan="1">_</td><td align="left" valign="middle" rowspan="1" colspan="1">Rat, glucose (3 mg/ml), p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B113" ref-type="bibr">113</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Rhizome / ethanolic</td><td align="left" valign="middle" rowspan="1" colspan="1">300 mg/kg, p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Males mice, glucose (1 g/kg), p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B114" ref-type="bibr">114</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leaves/ aqueous</td><td align="left" valign="middle" rowspan="1" colspan="1">10 mg/kg, p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Males and females rat</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B134" ref-type="bibr">134</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Seeds, stems, flowers, and bark/ aqueous</td><td align="left" valign="middle" rowspan="1" colspan="1">0.1, 0.092, 0.084, 0.071 and 0.05 g/ml, p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Males rat</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02193;BG</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B135" ref-type="bibr">135</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Stem bark/ ethanolic</td><td align="left" valign="middle" rowspan="1" colspan="1">15, 30, 60, 120 and 240 (&#x000b5;g/ml), p.o.</td><td align="left" valign="middle" rowspan="1" colspan="1">Males rat</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02191; Antioxidant markers<break/>&#x02193; LPO</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B136" ref-type="bibr">136</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Plant/ aqueous</td><td align="left" valign="middle" rowspan="1" colspan="1">25&#x02013;1000 &#x000b5;g/ml</td><td align="left" valign="middle" rowspan="1" colspan="1">INS-1 b-cells, glucose (5.6 mM) g/kg</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02191; Insulin release <break/>&#x02191; Glucose consumption</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B137" ref-type="bibr">137</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Plant/ aqueous</td><td align="left" valign="middle" rowspan="1" colspan="1">25&#x02013;1000 &#x000b5;g/ml</td><td align="left" valign="middle" rowspan="1" colspan="1">3T3-L1 adipocytes, glucose 5.6 mM) g/kg</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02191; Insulin release <break/>&#x02191; Glucose consumption</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="B137" ref-type="bibr">137</xref>)</td></tr></tbody></table><table-wrap-foot><p>&#x02191;: increase; &#x02193;: decrease; BG: blood glucose; GK: glucokinase; G6Pase: glucose-6-phosphatase; GluT4: glucose transporter 4; g: gram; HK: hexokinases; INS-1 b-cells: insulin-secreting cells; i.p.: intraperitoneal; I.V.: intravenous; kg: kilogram; LPO: lipid peroxidation; &#x000b5;g: microgram; &#x000b5;l: microliter; mg: milligram; ml:milliliter; PKC: protein kinase C; p.o.: per os (orally); s.c.: subcutaneous; STZ: streptozotocin</p></table-wrap-foot></table-wrap><fig id="F3" position="float"><label>Figure 3</label><caption><p>Main mechanisms of neem on diabetes. Neem has been shown protective effects against diabetes via inhibition of the mitochondrial/oxidative stress pathways</p></caption><graphic xlink:href="IJBMS-24-280-g003"/><p>GLUT2: glucose transporter 2; ROS: reactive oxygen species</p></fig></sec><sec sec-type="conclusions"><title>Conclusion</title><p>In summary, <italic>A</italic><italic>.</italic><italic> indica</italic> (neem) is effective in MetS and anti-oxidant effects appear to play an important role in protective mechanisms of neem against MetS and the complications associated with it. Neem increases the expression of Nrf2-mediated anti-oxidant enzymes and can regulate blood pressure and lipid profile. Also, neem inhibits vascular smooth muscle contraction through the block of calcium channels and decreases high blood pressure. Neem up-regulates eNOS expression as a vasodilator and increases NO level. Moreover, neem reduces vasoconstriction through the regulation of the ERK1/2 signaling pathway. In the diabetic condition, neem up-regulates GLUT4 and reduces the glucose uptake. Neem also inhibits intestinal enzymes such as glucosidases. Understanding the signaling pathways help to expand the use of neem in the treatment of the MetS. However, few studies have been conducted to investigate the anti-diabetic, anti-hypertension, anti-hyperlipidemia, and anti-obesity activities of neem in humans. Therefore, further clinical studies are needed to assess the protective effects of neem.</p></sec></body><back><ack><title>Acknowledgment</title><p>The authors are thankful to Mashhad University of Medical Sciences, Mashhad, Iran.</p></ack><sec><title>Conflicts of Interest</title><p>The authors declare that there are no conflicts of interest.</p></sec><ref-list><title>References</title><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>G</given-names></name><name><surname>Lindstrom</surname><given-names>J</given-names></name><name><surname>Jousilahti</surname><given-names>P</given-names></name><name><surname>Peltonen</surname><given-names>M</given-names></name><name><surname>Sjoberg</surname><given-names>L</given-names></name><name><surname>Kaaja</surname><given-names>R</given-names></name><name><surname>etal</surname><given-names/></name></person-group><article-title>The increasing prevalence of metabolic syndrome among Finnish men and women over a decade</article-title><source> J Clin Endocrinol Metab</source><year>2008</year><volume>93</volume><fpage>832</fpage><lpage>836</lpage><pub-id pub-id-type="pmid">18073296</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>W-Y</given-names></name><name><surname>Jung</surname><given-names>C-H</given-names></name><name><surname>Park</surname><given-names>J-S</given-names></name><name><surname>Rhee</surname><given-names>E-J</given-names></name><name><surname>Kim</surname><given-names>S-W</given-names></name></person-group><article-title>Effects of smoking, alcohol, exercise, education, and family history on the metabolic syndrome as defined by the ATP III</article-title><source> Diabetes Res Clin Pract</source><year>2005</year><volume>67</volume><fpage>70</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">15620436</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toms</surname><given-names>TE</given-names></name><name><surname>Panoulas</surname><given-names>VF</given-names></name><name><surname>John</surname><given-names>H</given-names></name><name><surname>Douglas</surname><given-names>KM</given-names></name><name><surname>Kitas</surname><given-names>GD</given-names></name></person-group><article-title>Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60-more than just an anti-inflammatory effect? A cross sectional study</article-title><source> Arthritis Res Ther</source><year>2009</year><volume>11</volume><fpage>R110</fpage><pub-id pub-id-type="pmid">19607680</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamilton</surname><given-names>MT</given-names></name><name><surname>Hamilton</surname><given-names>DG</given-names></name><name><surname>Zderic</surname><given-names>TW</given-names></name></person-group><article-title>Role of low energy expenditure and sitting in obesity, metabolic syndrome, type 2 diabetes, and cardiovascular disease</article-title><source> Diabetes</source><year>2007</year><volume>56</volume><fpage>2655</fpage><lpage>2667</lpage><pub-id pub-id-type="pmid">17827399</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahdian</surname><given-names>D</given-names></name><name><surname>Abbaszadeh-Goudarzi</surname><given-names>K</given-names></name><name><surname>Raoofi</surname><given-names>A</given-names></name><name><surname>Dadashizadeh</surname><given-names>G</given-names></name><name><surname>Abroudi</surname><given-names>M</given-names></name><name><surname>Zarepour</surname><given-names>E</given-names></name><name><surname>etal</surname><given-names/></name></person-group><article-title>Effect of Boswellia species on the metabolic syndrome: A review</article-title><source> Iran J Basic Med Sci.</source><year>2020</year><volume>23</volume><fpage>1374</fpage><lpage>1381</lpage><pub-id pub-id-type="pmid">33235693</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saeed</surname><given-names>A</given-names></name><name><surname>Feofanova</surname><given-names>EV</given-names></name><name><surname>Yu</surname><given-names>B</given-names></name><name><surname>Sun</surname><given-names>W</given-names></name><name><surname>Virani</surname><given-names>SS</given-names></name><name><surname>Nambi</surname><given-names>V</given-names></name><name><surname>etal</surname><given-names/></name></person-group><article-title>Remnant-like particle cholesterol, low-density lipoprotein triglycerides, and incident cardiovascular disease</article-title><source> J Am Coll Cardiol</source><year>2018</year><volume>72</volume><fpage>156</fpage><lpage>169</lpage><pub-id pub-id-type="pmid">29976289</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galavi</surname><given-names>A</given-names></name><name><surname>Hosseinzadeh</surname><given-names>H</given-names></name><name><surname>Razavi</surname><given-names>BM</given-names></name></person-group><article-title>The effects of Alliumcepa (onion) and its active constituents on metabolic syndrome: A review</article-title><source> Iran J Basic Med Sci.</source><year>2020</year><volume>23</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">32395203</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lonardo</surname><given-names>A</given-names></name><name><surname>Ballestri</surname><given-names>S</given-names></name><name><surname>Marchesini</surname><given-names>G</given-names></name><name><surname>Angulo</surname><given-names>P</given-names></name><name><surname>Loria</surname><given-names>P</given-names></name></person-group><article-title>Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome</article-title><source> Dig Liver Dis</source><year>2015</year><volume>47</volume><fpage>181</fpage><lpage>190</lpage><pub-id pub-id-type="pmid">25739820</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Floreani</surname><given-names>A</given-names></name><name><surname>Cazzagon</surname><given-names>N</given-names></name><name><surname>Franceschet</surname><given-names>I</given-names></name><name><surname>Canesso</surname><given-names>F</given-names></name><name><surname>Salmaso</surname><given-names>L</given-names></name><name><surname>Baldo</surname><given-names>V</given-names></name></person-group><article-title>Metabolic syndrome associated with primary biliary cirrhosis</article-title><source> J Clin Gastroenterol</source><year>2015</year><volume>49</volume><fpage>57</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">24231935</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>S</given-names></name><name><surname>Kakoly</surname><given-names>N</given-names></name><name><surname>Tan</surname><given-names>J</given-names></name><name><surname>Fitzgerald</surname><given-names>G</given-names></name><name><surname>Bahri</surname><given-names>Khomami M</given-names></name><name><surname>Joham</surname><given-names>A</given-names></name><name><surname>etal</surname><given-names/></name></person-group><article-title>Metabolic syndrome in polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression</article-title><source> Obe Rev</source><year>2019</year><volume>20</volume><fpage>339</fpage><lpage>352</lpage></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Czech</surname><given-names>MP</given-names></name></person-group><article-title>Insulin action and resistance in obesity and type 2 diabetes</article-title><source> Nat Med</source><year>2017</year><volume>23</volume><fpage>804</fpage><lpage>814</lpage><pub-id pub-id-type="pmid">28697184</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Liang</surname><given-names>F</given-names></name></person-group><article-title>Mechanisms linking inflammation to insulin resistance</article-title><source> Int J Endocrinol</source><year>2015</year><volume>2015</volume><fpage>508409</fpage><pub-id pub-id-type="pmid">26136779</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>M</given-names></name><name><surname>Yokotsuka</surname><given-names>M</given-names></name><name><surname>Yamaoka</surname><given-names>K</given-names></name><name><surname>Adachi</surname><given-names>M</given-names></name><name><surname>Nemoto</surname><given-names>A</given-names></name><name><surname>Tango</surname><given-names>T</given-names></name></person-group><article-title>Effects of a lifestyle modification programme to reduce the number of risk factors for metabolic syndrome: a randomised controlled trial</article-title><source> Public Health Nut</source><year>2017</year><volume>20</volume><fpage>142</fpage><lpage>153</lpage></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanati</surname><given-names>S</given-names></name><name><surname>Razavi</surname><given-names>BM</given-names></name><name><surname>Hosseinzadeh</surname><given-names>H</given-names></name></person-group><article-title>A review of the effects of Capsicumannuum L and its constituent, capsaicin, in metabolic syndrome</article-title><source> Iran J Basic Med Sci</source><year>2018</year><volume>21</volume><fpage>439</fpage><lpage>448</lpage><pub-id pub-id-type="pmid">29922422</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dehghani</surname><given-names>S</given-names></name><name><surname>Mehri</surname><given-names>S</given-names></name><name><surname>Hosseinzadeh</surname><given-names>H</given-names></name></person-group><article-title>The effects of Crataeguspinnatifida (Chinese hawthorn) on metabolic syndrome: A review</article-title><source> Iran J Basic Med Sci</source><year>2019</year><volume>22</volume><fpage>460</fpage><lpage>468</lpage><pub-id pub-id-type="pmid">31217924</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Razavi</surname><given-names>BM</given-names></name><name><surname>Lookian</surname><given-names>F</given-names></name><name><surname>Hosseinzadeh</surname><given-names>H</given-names></name></person-group><article-title>Protective effects of green tea on olanzapine-induced-metabolic syndrome in rats</article-title><source> Biomed Pharmacother</source><year>2017</year><volume>92</volume><fpage>726</fpage><lpage>731</lpage><pub-id pub-id-type="pmid">28586744</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>SC</given-names></name><name><surname>Prasad</surname><given-names>S</given-names></name><name><surname>Tyagi</surname><given-names>AK</given-names></name><name><surname>Kunnumakkara</surname><given-names>AB</given-names></name><name><surname>Aggarwal</surname><given-names>BB</given-names></name></person-group><article-title>Neem (Azadirachtaindica): An indian traditional panacea with modern molecular basis</article-title><source> Phytomedicine</source><year>2017</year><volume>34</volume><fpage>14</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">28899496</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selvaraj</surname><given-names>B</given-names></name><name><surname>Periyasamy</surname><given-names>S</given-names></name></person-group><article-title>Indian medicinal plants for diabetes: text data mining the literature of different electronic databases for future therapeutics</article-title><source> Biomed Res</source><year>2016</year><volume>27</volume><fpage>430</fpage><lpage>436</lpage></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>SM</given-names></name><name><surname>Venkata</surname><given-names>KCN</given-names></name><name><surname>Bhattacharyya</surname><given-names>P</given-names></name><name><surname>Sethi</surname><given-names>G</given-names></name><name><surname>Bishayee</surname><given-names>A</given-names></name></person-group><article-title>Potential of neem (Azadirachtaindica for prevention and treatment of oncologic diseases</article-title><source> Semin Cancer Biol</source><year>2016</year><volume>41</volume><fpage>100</fpage><lpage>115</lpage></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biswas</surname><given-names>K</given-names></name><name><surname>Chattopadhyay</surname><given-names>I</given-names></name><name><surname>Banerjee</surname><given-names>RK</given-names></name><name><surname>Bandyopadhyay</surname><given-names>U</given-names></name></person-group><article-title>Biological activities and medicinal properties of neem (Azadirachtaindica)</article-title><source> Curr Sci</source><year>2002</year><volume>82</volume><fpage>1336</fpage><lpage>1345</lpage></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nwobodo</surname><given-names>EI</given-names></name></person-group><article-title>Evaluation of antilipid peroxidation and hypolipidemic potentials of AzadirachtaIndica leaf aqueous extract in paracetamol-induced hepatotoxicity in wistar rats</article-title><source> Int J Inform Res Rev.</source><year>2017</year><volume>4</volume><fpage>3615</fpage><lpage>3619</lpage></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Igwenyi</surname><given-names>I</given-names></name><name><surname>Eze</surname><given-names>A</given-names></name><name><surname>Aja</surname><given-names>P</given-names></name><name><surname>Elom</surname><given-names>S</given-names></name><name><surname>Uraku</surname><given-names>A</given-names></name><name><surname>Awoke</surname><given-names>J</given-names></name><name><surname>etal</surname><given-names/></name></person-group><article-title>Cholesterol-lowering and hepatoprotective effect of fruit juice extract of Azadirachtaindica on Plasmodium berghei infected mice</article-title><source> Int J Curr Microbiol App Sci</source><year>2017</year><volume>6</volume><fpage>3367</fpage><lpage>3375</lpage></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moga</surname><given-names>MA</given-names></name><name><surname>B&#x00103;lan</surname><given-names>A</given-names></name><name><surname>Anastasiu</surname><given-names>CV</given-names></name><name><surname>Dimienescu</surname><given-names>OG</given-names></name><name><surname>Neculoiu</surname><given-names>CD</given-names></name><name><surname>Gavri&#x00219;</surname><given-names>C</given-names></name></person-group><article-title>An overview on the anticancer activity of Azadirachtaindica (Neem) in gynecological cancers</article-title><source> Int J Mol Sci</source><year>2018</year><volume>19</volume><fpage>3898</fpage><lpage>3924</lpage></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singaravelu</surname><given-names>S</given-names></name><name><surname>Sankarapillai</surname><given-names>J</given-names></name><name><surname>Chandrakumari</surname><given-names>AS</given-names></name><name><surname>Sinha</surname><given-names>P</given-names></name></person-group><article-title>Effect of Azadirachtaindica crude bark extracts concentrations against gram-positive and gram-negative bacterial pathogens</article-title><source> J Pharm Bioallied Sci</source><year>2019</year><volume>11</volume><fpage>33</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">30906137</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shakib</surname><given-names>Z</given-names></name><name><surname>Shahraki</surname><given-names>N</given-names></name><name><surname>Razavi</surname><given-names>BM</given-names></name><name><surname>Hosseinzadeh</surname><given-names>H</given-names></name></person-group><article-title>Aloe vera as an herbal medicine in the treatment of metabolic syndrome: A review</article-title><source> Phytother Res</source><year>2019</year><volume>33</volume><fpage>2649</fpage><lpage>2660</lpage><pub-id pub-id-type="pmid">31456283</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sonkusare</surname><given-names>S</given-names></name><name><surname>Palade</surname><given-names>PT</given-names></name><name><surname>Marsh</surname><given-names>JD</given-names></name><name><surname>Telemaque</surname><given-names>S</given-names></name><name><surname>Pesic</surname><given-names>A</given-names></name><name><surname>Rusch</surname><given-names>NJ</given-names></name></person-group><article-title>Vascular calcium channels and high blood pressure: pathophysiology and therapeutic implications</article-title><source> Vas Pharmacol</source><year>2006</year><volume>44</volume><fpage>131</fpage><lpage>142</lpage></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouallegue</surname><given-names>A</given-names></name><name><surname>Bou</surname><given-names>Daou G</given-names></name><name><surname>Srivastava</surname><given-names>AK</given-names></name></person-group><article-title>Endothelin-1-induced signaling pathways in vascular smooth muscle cells</article-title><source> Curr Vasc Pharmacol</source><year>2007</year><volume>5</volume><fpage>45</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">17266612</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ignarro</surname><given-names>LJ</given-names></name><name><surname>Kadowitz</surname><given-names>PJ</given-names></name></person-group><article-title>The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation</article-title><source> Annual Rev Pharmacol Toxicol</source><year>1985</year><volume>25</volume><fpage>171</fpage><lpage>191</lpage><pub-id pub-id-type="pmid">2988418</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howden</surname><given-names>R</given-names></name></person-group><article-title>Nrf2 and cardiovascular defense</article-title><source> Oxid Med Cell Longev</source><year>2013</year><volume>2013</volume><fpage>104308</fpage><pub-id pub-id-type="pmid">23691261</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>AJ</given-names></name><name><surname>Gilani</surname><given-names>A-H</given-names></name><name><surname>Hanif</surname><given-names>HM</given-names></name></person-group><article-title>Neem (Azadirachta indica) lowers blood pressure through a combination of Ca+ channel blocking and endothelium-dependent muscarinic receptors activation</article-title><source> Int J Pharmacol</source><year>2014</year><volume>10</volume><fpage>418</fpage><lpage>428</lpage></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Om&#x000f3;b&#x000f2;w&#x000e1;l&#x000e9;</surname><given-names>TO</given-names></name><name><surname>Oyagbemi</surname><given-names>AA</given-names></name><name><surname>Alaba</surname><given-names>BA</given-names></name><name><surname>Ola-Davies</surname><given-names>OE</given-names></name><name><surname>Adejumobi</surname><given-names>OA</given-names></name><name><surname>Asenuga</surname><given-names>ER</given-names></name><name><surname>etal</surname><given-names/></name></person-group><article-title>Ameliorative effect of Azadirachtaindica on sodium fluoride-induced hypertension through improvement of antioxidant defence system and upregulation of extracellular signal regulated kinase 1/2 signaling</article-title><source> J Basic Clin Physiol Pharmacol</source><year>2018</year><volume>29</volume><fpage>155</fpage><lpage>164</lpage><pub-id pub-id-type="pmid">28981443</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Om&#x000f3;b&#x000f2;w&#x000e1;l&#x000e9;</surname><given-names>TO</given-names></name><name><surname>Oyagbemi</surname><given-names>AA</given-names></name><name><surname>Ogunpolu</surname><given-names>BS</given-names></name><name><surname>Ola-Davies</surname><given-names>OE</given-names></name><name><surname>Olukunle</surname><given-names>JO</given-names></name><name><surname>Asenuga</surname><given-names>ER</given-names></name><etal/></person-group><article-title>Antihypertensive effect of polyphenol-rich fraction of Azadirachtaindica on N&#x003c9;-Nitro-L-arginine methyl ester-induced hypertension and cardiorenal dysfunction</article-title><source> Drug Res</source><year>2019</year><volume>69</volume><fpage>12</fpage><lpage>22</lpage></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obiefuna</surname><given-names>I</given-names></name><name><surname>Young</surname><given-names>R</given-names></name></person-group><article-title>Concurrent administration of aqueous Azadirachtaindica (neem) leaf extract with DOCA-salt prevents the development of hypertension and accompanying electrocardiogram changes in the rat</article-title><source> Phytother Res</source><year>2005</year><volume>19</volume><fpage>792</fpage><lpage>795</lpage><pub-id pub-id-type="pmid">16220573</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kochhar</surname><given-names>A</given-names></name><name><surname>Sharma</surname><given-names>N</given-names></name><name><surname>Sachdeva</surname><given-names>R</given-names></name></person-group><article-title>Effect of supplementation of Tulsi (Ocimumsanctum) and Neem (Azadirachtaindica) leaf powder on diabetic symptoms, anthropometric parameters and blood pressure of non insulin dependent male diabetics</article-title><source> Stud EthnoMed</source><year>2009</year><volume>3</volume><fpage>5</fpage><lpage>9</lpage></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tabeshpour</surname><given-names>J</given-names></name><name><surname>Imenshahidi</surname><given-names>M</given-names></name><name><surname>Hosseinzadeh</surname><given-names>H</given-names></name></person-group><article-title>A review of the effects of Berberisvulgaris and its major component, berberine, in metabolic syndrome</article-title><source> Iran J Basic Med Sci</source><year>2017</year><volume>20</volume><fpage>557</fpage><lpage>568</lpage><pub-id pub-id-type="pmid">28656091</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hassani</surname><given-names>FV</given-names></name><name><surname>Shirani</surname><given-names>K</given-names></name><name><surname>Hosseinzadeh</surname><given-names>H</given-names></name></person-group><article-title>Rosemary (Rosmarinusofficinalis) as a potential therapeutic plant in metabolic syndrome: a review</article-title><source> Naunyn-Schmiedeberg&#x02019;s Arch Pharmacol</source><year>2016</year><volume>389</volume><fpage>931</fpage><lpage>949</lpage><pub-id pub-id-type="pmid">27178264</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshino</surname><given-names>G</given-names></name><name><surname>Hirano</surname><given-names>T</given-names></name><name><surname>Kazumi</surname><given-names>T</given-names></name></person-group><article-title>Dyslipidemia in diabetes mellitus</article-title><source> Diabetes Res Clin Pract</source><year>1996</year><volume>33</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">8877270</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pirinccioglu</surname><given-names>AG</given-names></name><name><surname>G&#x000f6;kalp</surname><given-names>D</given-names></name><name><surname>Pirinccioglu</surname><given-names>M</given-names></name><name><surname>Kizil</surname><given-names>G</given-names></name><name><surname>Kizil</surname><given-names>M</given-names></name></person-group><article-title>Malondialdehyde (MDA) and protein carbonyl (PCO) levels as biomarkers of oxidative stress in subjects with familial hypercholesterolemia</article-title><source> Clin Biochem</source><year>2010</year><volume>43</volume><fpage>1220</fpage><lpage>1224</lpage><pub-id pub-id-type="pmid">20691171</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Demerdash</surname><given-names>FM</given-names></name><name><surname>Nasr</surname><given-names>HM</given-names></name></person-group><article-title>Antioxidant effect of selenium on lipid peroxidation, hyperlipidemia and biochemical parameters in rats exposed to diazinon</article-title><source> J Trace Elem Med Biol</source><year>2014</year><volume>28</volume><fpage>89</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">24188896</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morel</surname><given-names>DW</given-names></name><name><surname>Chisolm</surname><given-names>GM</given-names></name></person-group><article-title>Antioxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity</article-title><source> J Lipid Res</source><year>1989</year><volume>30</volume><fpage>1827</fpage><lpage>1834</lpage><pub-id pub-id-type="pmid">2621411</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Araujo</surname><given-names>FB</given-names></name><name><surname>Barbosa</surname><given-names>DS</given-names></name><name><surname>Hsin</surname><given-names>CY</given-names></name><name><surname>Maranh&#x000e3;o</surname><given-names>RC</given-names></name><name><surname>Abdalla</surname><given-names>DS</given-names></name></person-group><article-title>Evaluation of oxidative stress in patients with hyperlipidemia</article-title><source> Atherosclerosis</source><year>1995</year><volume>117</volume><fpage>61</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">8546756</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davignon</surname><given-names>J</given-names></name><name><surname>Cohn</surname><given-names>JS</given-names></name></person-group><article-title>Triglycerides: a risk factor for coronary heart disease</article-title><source> Atherosclerosis</source><year>1996</year><volume>124</volume><fpage>57</fpage><lpage>64</lpage></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soni</surname><given-names>H</given-names></name><name><surname>Patel</surname><given-names>S</given-names></name><name><surname>Patel</surname><given-names>G</given-names></name><name><surname>Paranjape</surname><given-names>A</given-names></name></person-group><article-title>Evaluation of anti-diabetic activity of Glucova Active Tablet on Type I and Type II diabetic model in rats</article-title><source> J Ayurveda Integr Med</source><year>2014</year><volume>5</volume><fpage>97</fpage><lpage>103</lpage><pub-id pub-id-type="pmid">24948860</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bisht</surname><given-names>S</given-names></name><name><surname>Sisodia</surname><given-names>S</given-names></name></person-group><article-title>Anti-hyperglycemic and antidyslipidemic potential of Azadirachtaindica leaf extract in STZ-induced diabetes mellitus</article-title><source> J Pharm Sci Res</source><year>2010</year><volume>2</volume><fpage>622</fpage><lpage>627</lpage></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hussain</surname><given-names>HEMA</given-names></name></person-group><article-title>Reversal of diabetic retinopathy in streptozotocin induced diabetic rats using traditional Indian anti-diabetic plant, Azadirachtaindica (L</article-title><source> ). Indian J Clin Biochem</source><year>2002</year><volume>17</volume><fpage>115</fpage><lpage>123</lpage><pub-id pub-id-type="pmid">23105362</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gutierrez</surname><given-names>RMP</given-names></name><name><surname>G&#x000f3;mez</surname><given-names>YGY</given-names></name><name><surname>Guzman</surname><given-names>MD</given-names></name></person-group><article-title>Attenuation of nonenzymatic glycation, hyperglycemia, and hyperlipidemia in streptozotocin-induced diabetic rats by chloroform leaf extract of Azadirachtaindica</article-title><source> Pharmacogn Mag</source><year>2011</year><volume>7</volume><fpage>254</fpage><lpage>259</lpage><pub-id pub-id-type="pmid">21969798</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Satyanarayana</surname><given-names>K</given-names></name><name><surname>Sravanthi</surname><given-names>K</given-names></name><name><surname>Shaker</surname><given-names>IA</given-names></name><name><surname>Ponnulakshmi</surname><given-names>R</given-names></name></person-group><article-title>Molecular approach to identify antidiabetic potential of Azadirachtaindica</article-title><source> J Ayurveda Integr Med</source><year>2015</year><volume>6</volume><fpage>165</fpage><lpage>174</lpage><pub-id pub-id-type="pmid">26604551</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gautam</surname><given-names>MK</given-names></name><name><surname>Gangwar</surname><given-names>M</given-names></name><name><surname>Singh</surname><given-names>SK</given-names></name><name><surname>Goel</surname><given-names>RK</given-names></name></person-group><article-title>Effects of Azardirachtaindica on vascular endothelial growth factor and cytokines in diabetic deep wound</article-title><source> Planta Med</source><year>2015</year><volume>81</volume><fpage>713</fpage><lpage>721</lpage><pub-id pub-id-type="pmid">26069952</pub-id></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mutalik</surname><given-names>S</given-names></name><name><surname>Chetana</surname><given-names>M</given-names></name><name><surname>Sulochana</surname><given-names>B</given-names></name><name><surname>Devi</surname><given-names>PU</given-names></name><name><surname>Udupa</surname><given-names>N</given-names></name></person-group><article-title>Effect of Dianex, a herbal formulation on experimentally induced diabetes mellitus</article-title><source> Phytother Res</source><year>2005</year><volume>19</volume><fpage>409</fpage><lpage>415</lpage><pub-id pub-id-type="pmid">16106394</pub-id></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez-Gutierrez</surname><given-names>RM</given-names></name><name><surname>Damian-Guzman</surname><given-names>M</given-names></name></person-group><article-title>Meliacinolin: a potent &#x003b1;-glucosidase and &#x003b1;-amylase inhibitor isolated from Azadirachtaindica leaves and invivo antidiabetic property in streptozotocin-nicotinamide-induced type 2 diabetes in mice</article-title><source> Biol Pharm Bull</source><year>2012</year><volume>35</volume><fpage>1516</fpage><lpage>1524</lpage><pub-id pub-id-type="pmid">22975503</pub-id></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bangar</surname><given-names>OP</given-names></name><name><surname>Jarald</surname><given-names>EE</given-names></name><name><surname>Asghar</surname><given-names>S</given-names></name><name><surname>Ahmad</surname><given-names>S</given-names></name></person-group><article-title>Antidiabetic activity of a polyherbal formulation (Karnim Plus)</article-title><source> Int J Green Pharm</source><year>2009</year><volume>3</volume><fpage>211</fpage><lpage>214</lpage></element-citation></ref><ref id="B52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dholi</surname><given-names>SK</given-names></name><name><surname>Raparla</surname><given-names>R</given-names></name><name><surname>Mankala</surname><given-names>SK</given-names></name><name><surname>Nagappan</surname><given-names>K</given-names></name></person-group><article-title>Invivo Antidiabetic evaluation of Neem leaf extract in alloxan induced rats</article-title><source> J App Pharm Sci</source><year>2011</year><volume>1</volume><fpage>100</fpage><lpage>105</lpage></element-citation></ref><ref id="B53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mgbeje</surname><given-names>BAI</given-names></name><name><surname>Essien</surname><given-names>NA</given-names></name><name><surname>Iwara</surname><given-names>IA</given-names></name><name><surname>Egbung</surname><given-names>GE</given-names></name><name><surname>Igile</surname><given-names>GO</given-names></name><name><surname>Ebong</surname><given-names>PE</given-names></name></person-group><article-title>Lipid profile and hepatoprotective effects of combined leaf extracts of AzadirachtaIndica (Neem) and Peristrophebicalyculata in Alloxan-induced diabetic rats</article-title><source> Int J Phytomedicine</source><year>2013</year><volume>5</volume><fpage>159</fpage><lpage>162</lpage></element-citation></ref><ref id="B54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peer</surname><given-names>PA</given-names></name><name><surname>Trivedi</surname><given-names>PC</given-names></name><name><surname>Nigade</surname><given-names>PB</given-names></name><name><surname>Ghaisas</surname><given-names>MM</given-names></name><name><surname>Deshpande</surname><given-names>AD</given-names></name></person-group><article-title>Cardioprotective effect of Azadirachtaindica A Juss on isoprenaline induced myocardial infarction in rats</article-title><source> Int J Cardiol</source><year>2008</year><volume>126</volume><fpage>123</fpage><lpage>126</lpage><pub-id pub-id-type="pmid">17467089</pub-id></element-citation></ref><ref id="B55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuraini</surname><given-names>A</given-names></name><name><surname>Vadiveloo</surname><given-names>T</given-names></name><name><surname>Hidayat</surname><given-names>MT</given-names></name><name><surname>Arifah</surname><given-names>A</given-names></name><name><surname>Sulaiman</surname><given-names>M</given-names></name><name><surname>Somchit</surname><given-names>M</given-names></name></person-group><article-title>Effects of neem (Azadirachtaindica) leaf extracts on lipid and C-reactive protein concentrations in cholesterol-fed rats</article-title><source> J Nat Remedies</source><year>2006</year><volume>6</volume><fpage>109</fpage><lpage>114</lpage></element-citation></ref><ref id="B56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wyatt</surname><given-names>SB</given-names></name><name><surname>Winters</surname><given-names>KP</given-names></name><name><surname>Dubbert</surname><given-names>PM</given-names></name></person-group><article-title>Overweight and obesity: prevalence, consequences, and causes of a growing public health problem</article-title><source> Am J Med Sci</source><year>2006</year><volume>331</volume><fpage>166</fpage><lpage>174</lpage><pub-id pub-id-type="pmid">16617231</pub-id></element-citation></ref><ref id="B57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boden-Albala</surname><given-names>B</given-names></name><name><surname>Sacco</surname><given-names>RL</given-names></name></person-group><article-title>Lifestyle factors and stroke risk: exercise, alcohol, diet, obesity, smoking, drug use, and stress</article-title><source> Curr Atheroscler Rep</source><year>2000</year><volume>2</volume><fpage>160</fpage><lpage>166</lpage><pub-id pub-id-type="pmid">11122740</pub-id></element-citation></ref><ref id="B58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malnick</surname><given-names>SD</given-names></name><name><surname>Knobler</surname><given-names>H</given-names></name></person-group><article-title>The medical complications of obesity</article-title><source> J Assoc Physicians</source><year>2006</year><volume>99</volume><fpage>565</fpage><lpage>579</lpage></element-citation></ref><ref id="B59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukherjee</surname><given-names>A</given-names></name><name><surname>Sengupta</surname><given-names>S</given-names></name></person-group><article-title>Indian medicinal plants known to contain intestinal glucosidase inhibitors also inhibit pancreatic lipase activity&#x02014;An ideal situation for obesity control by herbal drugs</article-title><source> Indian J Biotechnol</source><year>2013</year><volume>12</volume><fpage>32</fpage><lpage>39</lpage></element-citation></ref><ref id="B60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jayakumar</surname><given-names>K</given-names></name><name><surname>Srinivasan</surname><given-names>M</given-names></name><name><surname>Ramesh</surname><given-names>N</given-names></name><name><surname>Sachan</surname><given-names>A</given-names></name><name><surname>Umesh</surname><given-names>M</given-names></name><name><surname>Narayana</surname><given-names>K</given-names></name></person-group><article-title>Effect of neem leaf extract on feed intake and body weight in rats</article-title><source> Indian Vet J</source><year>2002</year><volume>79</volume><fpage>732</fpage><lpage>733</lpage></element-citation></ref><ref id="B61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bogardus</surname><given-names>C</given-names></name><name><surname>Lillioja</surname><given-names>S</given-names></name><name><surname>Howard</surname><given-names>B</given-names></name><name><surname>Reaven</surname><given-names>G</given-names></name><name><surname>Mott</surname><given-names>D</given-names></name></person-group><article-title>Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects</article-title><source> J Clin Inves</source><year>1984</year><volume>74</volume><fpage>1238</fpage><lpage>1246</lpage></element-citation></ref><ref id="B62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dixit</surname><given-names>S</given-names></name><name><surname>Maiya</surname><given-names>A</given-names></name></person-group><article-title>Diabetic peripheral neuropathy and its evaluation in a clinical scenario: a review</article-title><source> J Postgrad Med</source><year>2014</year><volume>60</volume><fpage>33</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">24625937</pub-id></element-citation></ref><ref id="B63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaessen</surname><given-names>N</given-names></name><name><surname>Heutink</surname><given-names>P</given-names></name><name><surname>Janssen</surname><given-names>JA</given-names></name><name><surname>Witteman</surname><given-names>JC</given-names></name><name><surname>Testers</surname><given-names>L</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>etal</surname><given-names/></name></person-group><article-title>A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction</article-title><source> Diabetes</source><year>2001</year><volume>50</volume><fpage>637</fpage><lpage>642</lpage><pub-id pub-id-type="pmid">11246885</pub-id></element-citation></ref><ref id="B64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beckman</surname><given-names>JA</given-names></name><name><surname>Creager</surname><given-names>MA</given-names></name><name><surname>Libby</surname><given-names>P</given-names></name></person-group><article-title>Diabetes and atherosclerosis: epidemiology, pathophysiology, and management</article-title><source> Jama</source><year>2002</year><volume>287</volume><fpage>2570</fpage><lpage>2581</lpage><pub-id pub-id-type="pmid">12020339</pub-id></element-citation></ref><ref id="B65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritz</surname><given-names>E</given-names></name><name><surname>Rychl&#x000ed;k</surname><given-names>I</given-names></name><name><surname>Locatelli</surname><given-names>F</given-names></name><name><surname>Halimi</surname><given-names>S</given-names></name></person-group><article-title>End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions</article-title><source> Am J Kidney Dis</source><year>1999</year><volume>34</volume><fpage>795</fpage><lpage>808</lpage><pub-id pub-id-type="pmid">10561134</pub-id></element-citation></ref><ref id="B66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>H&#x000f6;rle</surname><given-names>S</given-names></name><name><surname>Gr&#x000fc;ner</surname><given-names>F</given-names></name><name><surname>Kroll</surname><given-names>P</given-names></name></person-group><article-title>Epidemiology of diabetes-induced blindness-a review</article-title><source> Klin Monbl Augenheilkd</source><year>2002</year><volume>219</volume><fpage>777</fpage><lpage>784</lpage><pub-id pub-id-type="pmid">12494367</pub-id></element-citation></ref><ref id="B67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coffey</surname><given-names>L</given-names></name><name><surname>Gallagher</surname><given-names>P</given-names></name><name><surname>Horgan</surname><given-names>O</given-names></name><name><surname>Desmond</surname><given-names>D</given-names></name><name><surname>MacLachlan</surname><given-names>M</given-names></name></person-group><article-title>Psychosocial adjustment to diabetes-related lower limb amputation</article-title><source> Diabetic Med</source><year>2009</year><volume>26</volume><fpage>1063</fpage><lpage>1067</lpage><pub-id pub-id-type="pmid">19900240</pub-id></element-citation></ref><ref id="B68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cade</surname><given-names>WT</given-names></name></person-group><article-title>Diabetes-related microvascular and macrovascular diseases in the physical therapy setting</article-title><source> Phys Ther Assoc</source><year>2008</year><volume>88</volume><fpage>1322</fpage><lpage>1335</lpage></element-citation></ref><ref id="B69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rains</surname><given-names>JL</given-names></name><name><surname>Jain</surname><given-names>SK</given-names></name></person-group><article-title>Oxidative stress, insulin signaling, and diabetes</article-title><source> Free Radic Biol Med</source><year>2011</year><volume>50</volume><fpage>567</fpage><lpage>575</lpage><pub-id pub-id-type="pmid">21163346</pub-id></element-citation></ref><ref id="B70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matough</surname><given-names>FA</given-names></name><name><surname>Budin</surname><given-names>SB</given-names></name><name><surname>Hamid</surname><given-names>ZA</given-names></name><name><surname>Alwahaibi</surname><given-names>N</given-names></name><name><surname>Mohamed</surname><given-names>J</given-names></name></person-group><article-title>The role of oxidative stress and antioxidants in diabetic complications</article-title><source> Sultan Qaboos Univ Med J</source><year>2012</year><volume>12</volume><fpage>5</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">22375253</pub-id></element-citation></ref><ref id="B71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pi</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Fu</surname><given-names>J</given-names></name><name><surname>Woods</surname><given-names>CG</given-names></name><name><surname>Hou</surname><given-names>Y</given-names></name><name><surname>Corkey</surname><given-names>BE</given-names></name><etal/></person-group><article-title>ROS signaling, oxidative stress and Nrf2 in pancreatic beta-cell function</article-title><source> Toxicol Appl Pharmacol</source><year>2010</year><volume>244</volume><fpage>77</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">19501608</pub-id></element-citation></ref><ref id="B72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>Y</given-names></name><name><surname>Tran</surname><given-names>POT</given-names></name><name><surname>Harmon</surname><given-names>J</given-names></name><name><surname>Robertson</surname><given-names>RP</given-names></name></person-group><article-title>A role for glutathione peroxidase in protecting pancreatic &#x003b2; cells against oxidative stress in a model of glucose toxicity</article-title><source> Proc Natl Acad Sci</source><year>2002</year><volume>99</volume><fpage>12363</fpage><lpage>12368</lpage><pub-id pub-id-type="pmid">12218186</pub-id></element-citation></ref><ref id="B73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tadera</surname><given-names>K</given-names></name><name><surname>Minami</surname><given-names>Y</given-names></name><name><surname>Takamatsu</surname><given-names>K</given-names></name><name><surname>Matsuoka</surname><given-names>T</given-names></name></person-group><article-title>Inhibition of &#x003b1;-glucosidase and &#x003b1;-amylase by flavonoids</article-title><source> J Nutr Sci Vitaminol</source><year>2006</year><volume>52</volume><fpage>149</fpage><lpage>153</lpage><pub-id pub-id-type="pmid">16802696</pub-id></element-citation></ref><ref id="B74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tundis</surname><given-names>R</given-names></name><name><surname>Loizzo</surname><given-names>M</given-names></name><name><surname>Menichini</surname><given-names>F</given-names></name></person-group><article-title>Natural products as &#x003b1;-amylase and &#x003b1;-glucosidase inhibitors and their hypoglycaemic potential in the treatment of diabetes: an update</article-title><source> Mini Rev Med Chem</source><year>2010</year><volume>10</volume><fpage>315</fpage><lpage>331</lpage><pub-id pub-id-type="pmid">20470247</pub-id></element-citation></ref><ref id="B75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>St</surname><given-names>Augustines T</given-names></name></person-group><article-title>Effects of Vernoniaamygdalina on biochemical and hematological parameters in diabetic rats</article-title><source> Asian J Med Sci</source><year>2009</year><volume>1</volume><fpage>108</fpage><lpage>113</lpage></element-citation></ref><ref id="B76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Razavi</surname><given-names>B</given-names></name><name><surname>Hosseinzadeh</surname><given-names>H</given-names></name></person-group><article-title>A review of the effects of Nigellasativa and its constituent, thymoquinone, in metabolic syndrome</article-title><source> J Endocrinol Invest</source><year>2014</year><volume>37</volume><fpage>1031</fpage><lpage>1040</lpage><pub-id pub-id-type="pmid">25125023</pub-id></element-citation></ref><ref id="B77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akaberi</surname><given-names>M</given-names></name><name><surname>Hosseinzadeh</surname><given-names>H</given-names></name></person-group><article-title>Grapes (Vitisvinifera) as a potential candidate for the therapy of the metabolic syndrome</article-title><source> Phytother Res</source><year>2016</year><volume>30</volume><fpage>540</fpage><lpage>556</lpage><pub-id pub-id-type="pmid">26800498</pub-id></element-citation></ref><ref id="B78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hosseini</surname><given-names>A</given-names></name><name><surname>Hosseinzadeh</surname><given-names>H</given-names></name></person-group><article-title>A review on the effects of Alliumsativum (Garlic) in metabolic syndrome</article-title><source> J Endocrinol Invest</source><year>2015</year><volume>38</volume><fpage>1147</fpage><lpage>1157</lpage><pub-id pub-id-type="pmid">26036599</pub-id></element-citation></ref><ref id="B79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joseph</surname><given-names>B</given-names></name><name><surname>Jini</surname><given-names>D</given-names></name></person-group><article-title>Insight into the hypoglycaemic effect of traditional Indian herbs used in the treatment of diabetes</article-title><source> Res J Med Plant</source><year>2011</year><volume>5</volume><fpage>352</fpage><lpage>376</lpage></element-citation></ref><ref id="B80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yaseen</surname><given-names>G</given-names></name><name><surname>Ahmad</surname><given-names>M</given-names></name><name><surname>Zafar</surname><given-names>M</given-names></name><name><surname>Sultana</surname><given-names>S</given-names></name><name><surname>Kayani</surname><given-names>S</given-names></name><name><surname>Cetto</surname><given-names>AA</given-names></name><etal/></person-group><article-title>Traditional management of diabetes in Pakistan: ethnobotanical investigation from traditional health practitioners</article-title><source> J Ethnopharmacol</source><year>2015</year><volume>174</volume><fpage>91</fpage><lpage>117</lpage><pub-id pub-id-type="pmid">26231447</pub-id></element-citation></ref><ref id="B81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dineshkumar</surname><given-names>B</given-names></name><name><surname>Analava</surname><given-names>M</given-names></name><name><surname>Manjunatha</surname><given-names>M</given-names></name></person-group><article-title>Antidiabetic and hypolipidaemic effects of few common plants extract in type 2 diabetic patients at Bengal</article-title><source> Int J Diabetes Metabo</source><year>2010</year><volume>18</volume><fpage>59</fpage><lpage>65</lpage></element-citation></ref><ref id="B82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riyanti</surname><given-names>S</given-names></name><name><surname>Suganda</surname><given-names>AG</given-names></name><name><surname>Sukandar</surname><given-names>EY</given-names></name></person-group><article-title>Dipeptidyl peptidase-IV inhibitory activity of some Indonesian medicinal plants</article-title><source> Asian J Pharm Clin Res.</source><year>2016</year><volume>9</volume><fpage>375</fpage><lpage>377</lpage></element-citation></ref><ref id="B83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ezuruike</surname><given-names>U</given-names></name><name><surname>Prieto</surname><given-names>JM</given-names></name></person-group><article-title>Assessment of potential herb-drug interactions among Nigerian adults with Type-2 diabetes</article-title><source> Front Pharmacol</source><year>2016</year><volume>7</volume><fpage>248</fpage><lpage>255</lpage><pub-id pub-id-type="pmid">27559312</pub-id></element-citation></ref><ref id="B84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rameshrad</surname><given-names>M</given-names></name><name><surname>Razavi</surname><given-names>BM</given-names></name><name><surname>Ferns</surname><given-names>GA</given-names></name><name><surname>Hosseinzadeh</surname><given-names>H</given-names></name></person-group><article-title>Pharmacology of dipeptidyl peptidase-4 inhibitors and its use in the management of metabolic syndrome: a comprehensive review on drug repositioning</article-title><source> DARU J Pharm Sci</source><year>2019</year><volume>27</volume><fpage>341</fpage><lpage>360</lpage></element-citation></ref><ref id="B85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rameshrad</surname><given-names>M</given-names></name><name><surname>Razavi</surname><given-names>BM</given-names></name><name><surname>Lalau</surname><given-names>J-D</given-names></name><name><surname>De</surname><given-names>Broe ME</given-names></name><name><surname>Hosseinzadeh</surname><given-names>H</given-names></name></person-group><article-title>An overview of glucagon-like peptide-1 receptor agonists for the treatment of metabolic syndrome: A drug repositioning</article-title><source> Iran J Basic Med Sci</source><year>2020</year><volume>23</volume><fpage>556</fpage><lpage>568</lpage><pub-id pub-id-type="pmid">32742592</pub-id></element-citation></ref><ref id="B86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>BD</given-names></name><name><surname>Flatt</surname><given-names>PR</given-names></name><name><surname>Bailey</surname><given-names>CJ</given-names></name></person-group><article-title>Dipeptidyl peptidase IV (DPP IV) inhibitors: a newly emerging drug class for the treatment of type 2 diabetes</article-title><source> Diabetes Vasc Dis Res</source><year>2006</year><volume>3</volume><fpage>159</fpage><lpage>165</lpage></element-citation></ref><ref id="B87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsia</surname><given-names>SH</given-names></name><name><surname>Bazargan</surname><given-names>M</given-names></name><name><surname>Davidson</surname><given-names>MB</given-names></name></person-group><article-title>Effect of Pancreas Tonic (an ayurvedic herbal supplement) in type 2 diabetes mellitus</article-title><source> Metabolism</source><year>2004</year><volume>53</volume><fpage>1166</fpage><lpage>1173</lpage><pub-id pub-id-type="pmid">15334379</pub-id></element-citation></ref><ref id="B88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lenzen</surname><given-names>S</given-names></name></person-group><article-title>The mechanisms of alloxan-and streptozotocin-induced diabetes</article-title><source> Diabetologia</source><year>2008</year><volume>51</volume><fpage>216</fpage><lpage>226</lpage><pub-id pub-id-type="pmid">18087688</pub-id></element-citation></ref><ref id="B89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dholi</surname><given-names>SK</given-names></name><name><surname>Raparla</surname><given-names>R</given-names></name><name><surname>Kannappan</surname><given-names>S</given-names></name></person-group><article-title>Synergic activity of fenugreek seeds and neem leaf extracts against alloxan induced diabetic rats</article-title><source> Int J PharmTech Res</source><year>2011</year><volume>3</volume><fpage>1963</fpage><lpage>1970</lpage></element-citation></ref><ref id="B90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patil</surname><given-names>P</given-names></name><name><surname>Patil</surname><given-names>S</given-names></name><name><surname>Mane</surname><given-names>A</given-names></name><name><surname>Verma</surname><given-names>S</given-names></name></person-group><article-title>Antidiabetic activity of alcoholic extract of Neem (Azadirachtaindica) root bark</article-title><source> Nat J Physiol Pharm Pharmacol</source><year>2013</year><volume>3</volume><fpage>142</fpage><lpage>146</lpage></element-citation></ref><ref id="B91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sunarwidhi</surname><given-names>AL</given-names></name><name><surname>Sudarsono</surname><given-names>S</given-names></name><name><surname>Nugroho</surname><given-names>AE</given-names></name></person-group><article-title>Hypoglycemic effect of combination of Azadirachtaindica and Gynuraprocumbens (Lour ) Mer ethanolic extracts standardized by rutin and quercetin in alloxan-induced hyperglycemic rats</article-title><source> Adv Pharm Bull</source><year>2014</year><volume>4</volume><fpage>613</fpage><lpage>618</lpage><pub-id pub-id-type="pmid">25671197</pub-id></element-citation></ref><ref id="B92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shailey</surname><given-names>S</given-names></name><name><surname>Basir</surname><given-names>SF</given-names></name></person-group><article-title>Protective role of Azadirachtaindica against oxidative damage in skeletal and cardiac muscle of alloxan diabetic rats</article-title><source> Int J Pharm Sci</source><year>2012</year><volume>4</volume><fpage>471</fpage><lpage>477</lpage></element-citation></ref><ref id="B93"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shailey</surname><given-names>S</given-names></name><name><surname>Basir</surname><given-names>SF</given-names></name></person-group><article-title>Strengthening of anti-oxidant defense by Azadirachtaindica in alloxan-diabetic rat tissues</article-title><source> J Ayurveda Integ Med</source><year>2012</year><volume>3</volume><fpage>130</fpage><lpage>135</lpage></element-citation></ref><ref id="B94"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karole</surname><given-names>S</given-names></name><name><surname>Shrivastava</surname><given-names>S</given-names></name><name><surname>Thomas</surname><given-names>S</given-names></name><name><surname>Soni</surname><given-names>B</given-names></name><name><surname>Khan</surname><given-names>S</given-names></name><name><surname>Dubey</surname><given-names>J</given-names></name><etal/></person-group><article-title>Polyherbal Formulation Concept for Synergic Action: A Review</article-title><source> J Drug Deliv Ther</source><year>2019</year><volume>9</volume><fpage>453</fpage><lpage>466</lpage></element-citation></ref><ref id="B95"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>TK</surname><given-names>MM</given-names></name><name><surname>TE</surname><given-names>FH</given-names></name><name><surname>Musambil</surname><given-names>M</given-names></name><name><surname>Mirshad</surname><given-names>P</given-names></name><name><surname>OM</surname><given-names>FR</given-names></name><name><surname>Vasudevan</surname><given-names>M</given-names></name></person-group><article-title>The effect of polyherbal formulation DIA7 on fasting blood glucose level in alloxan induced diabetic rats</article-title><source> Der Pharm Lett</source><year>2014</year><volume>6</volume><fpage>215</fpage><lpage>221</lpage></element-citation></ref><ref id="B96"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akhtar</surname><given-names>N</given-names></name><name><surname>Khan</surname><given-names>BA</given-names></name><name><surname>Majid</surname><given-names>A</given-names></name><name><surname>Khan</surname><given-names>S</given-names></name><name><surname>Mahmood</surname><given-names>T</given-names></name><name><surname>Gulfishan</surname><given-names>ST</given-names></name></person-group><article-title>Pharmaceutical and biopharmaceutical evaluation of extracts from different plant parts of indigenous origin for their hypoglycemic responses in rabbits</article-title><source> Acta Pol Pharm</source><year>2011</year><volume>68</volume><fpage>919</fpage><lpage>925</lpage><pub-id pub-id-type="pmid">22125958</pub-id></element-citation></ref><ref id="B97"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khosla</surname><given-names>P</given-names></name><name><surname>Bhanwra</surname><given-names>S</given-names></name><name><surname>Singh</surname><given-names>J</given-names></name><name><surname>Seth</surname><given-names>S</given-names></name><name><surname>Srivastava</surname><given-names>R</given-names></name></person-group><article-title>A study of hypoglycaemic effects of Azadirachtaindica (Neem) in normal and alloxan diabetic rabbits</article-title><source> Indian J Physiol Pharmacol</source><year>2000</year><volume>44</volume><fpage>69</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">10919098</pub-id></element-citation></ref><ref id="B98"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Upreti</surname><given-names>J</given-names></name><name><surname>Ali</surname><given-names>S</given-names></name><name><surname>Basir</surname><given-names>SF</given-names></name></person-group><article-title>Effect of lower doses of vanadate in combination with Azadirachtaindica leaf extract on hepatic and renal antioxidant enzymes in streptozotocin-induced diabetic rats</article-title><source> Biol Trace Elem Res</source><year>2013</year><volume>156</volume><fpage>202</fpage><lpage>209</lpage><pub-id pub-id-type="pmid">24081779</pub-id></element-citation></ref><ref id="B99"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>NK</given-names></name><name><surname>Srivastva</surname><given-names>N</given-names></name><name><surname>Puri</surname><given-names>S</given-names></name><name><surname>Bubber</surname><given-names>P</given-names></name><name><surname>Puri</surname><given-names>V</given-names></name></person-group><article-title>Neuroprotective potential of Azadirachtaindica leaves in diabetic rats</article-title><source> Asian J Pharm Clin Res</source><year>2017</year><volume>10</volume><fpage>243</fpage><lpage>248</lpage></element-citation></ref><ref id="B100"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atangwho</surname><given-names>IJ</given-names></name><name><surname>Ebong</surname><given-names>PE</given-names></name><name><surname>Egbung</surname><given-names>GE</given-names></name><name><surname>Ani</surname><given-names>IF</given-names></name></person-group><article-title>Effects of co-administration of extracts of Vernoniaamygdalina and Azadirachtaindica on serum electrolyte profile of diabetic and non diabetic rats</article-title><source> Australian J Basic Appl Sci</source><year>2009</year><volume>3</volume><fpage>2974</fpage><lpage>2978</lpage></element-citation></ref><ref id="B101"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akinola</surname><given-names>OB</given-names></name><name><surname>Caxton-Martins</surname><given-names>EA</given-names></name><name><surname>Dini</surname><given-names>L</given-names></name></person-group><article-title>Chronic treatment with ethanolic extract of the leaves of Azadirachtaindica ameliorates lesions of pancreatic islets in streptozotocin diabetes</article-title><source> Int J Morphol</source><year>2010</year><fpage>28;291</fpage><lpage>302</lpage></element-citation></ref><ref id="B102"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dallaqua</surname><given-names>B</given-names></name><name><surname>Saito</surname><given-names>FH</given-names></name><name><surname>Rodrigues</surname><given-names>T</given-names></name><name><surname>Calderon</surname><given-names>IMP</given-names></name><name><surname>Rudge</surname><given-names>MVC</given-names></name><name><surname>Herrera</surname><given-names>E</given-names></name><etal/></person-group><article-title>Treatment with Azadirachtaindica in diabetic pregnant rats: negative effects on maternal outcome</article-title><source> J Ethnopharmacol</source><year>2012</year><volume>143</volume><fpage>805</fpage><lpage>811</lpage><pub-id pub-id-type="pmid">22921950</pub-id></element-citation></ref><ref id="B103"><label>103</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atangwho</surname><given-names>IJ</given-names></name><name><surname>Ebong</surname><given-names>PE</given-names></name><name><surname>Eyong</surname><given-names>EU</given-names></name><name><surname>Asmawi</surname><given-names>MZ</given-names></name><name><surname>Ahmad</surname><given-names>M</given-names></name></person-group><article-title>Synergistic antidiabetic activity of Vernoniaamygdalina and Azadirachtaindica: Biochemical effects and possible mechanism</article-title><source> J Ethnopharmacol</source><year>2012</year><volume>141</volume><fpage>878</fpage><lpage>887</lpage><pub-id pub-id-type="pmid">22521731</pub-id></element-citation></ref><ref id="B104"><label>104</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez</surname><given-names>Gutierrez RM</given-names></name><name><surname>de</surname><given-names>Jesus Martinez Ortiz M</given-names></name></person-group><article-title>Beneficial effect of Azadirachtaindica on advanced glycation end-product in streptozotocin-diabetic rat</article-title><source> Pharm Biol</source><year>2014</year><volume>52</volume><fpage>1435</fpage><lpage>1444</lpage><pub-id pub-id-type="pmid">25026338</pub-id></element-citation></ref><ref id="B105"><label>105</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>NK</given-names></name><name><surname>Srivastva</surname><given-names>N</given-names></name><name><surname>Bubber</surname><given-names>P</given-names></name><name><surname>Puri</surname><given-names>S</given-names></name></person-group><article-title>The antioxidant potential of Azadirachta indica ameliorates cardioprotection following diabetic mellitus-induced microangiopathy</article-title><source> Pharmacogn Mag</source><year>2016</year><volume>12</volume><fpage>371</fpage></element-citation></ref><ref id="B106"><label>106</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minokoshi</surname><given-names>Y</given-names></name><name><surname>Kahn</surname><given-names>CR</given-names></name><name><surname>Kahn</surname><given-names>BB</given-names></name></person-group><article-title>Tissue-specific ablation of the GLUT4 glucose transporter or the insulin receptor challenges assumptions about insulin action and glucose homeostasis</article-title><source> J Biol Chem</source><year>2003</year><volume>278</volume><fpage>33609</fpage><lpage>33612</lpage><pub-id pub-id-type="pmid">12788932</pub-id></element-citation></ref><ref id="B107"><label>107</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>R</given-names></name><name><surname>Arora</surname><given-names>V</given-names></name><name><surname>Ram</surname><given-names>V</given-names></name><name><surname>Bhandari</surname><given-names>A</given-names></name><name><surname>Vyas</surname><given-names>P</given-names></name></person-group><article-title>Hypoglycemic and hypolipidemic effect of Allopolyherbal formulations in streptozotocin induced diabetes mellitus in rats</article-title><source> Int J Diabetes Mellit</source><year>2015</year><volume>3</volume><fpage>45</fpage><lpage>50</lpage></element-citation></ref><ref id="B108"><label>108</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>SS</given-names></name><name><surname>Shah</surname><given-names>RS</given-names></name><name><surname>Goyal</surname><given-names>RK</given-names></name></person-group><article-title>Antihyperglycemic, antihyperlipidemic and anti-oxidant effects of Dihar, a polyherbal ayurvedic formulation in streptozotocin induced diabetic rats</article-title><source> Indian J Exp Biol</source><year>2009</year><volume>47</volume><fpage>564</fpage><lpage>570</lpage><pub-id pub-id-type="pmid">19761040</pub-id></element-citation></ref><ref id="B109"><label>109</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yadav</surname><given-names>D</given-names></name><name><surname>Chaudhary</surname><given-names>AA</given-names></name><name><surname>Garg</surname><given-names>V</given-names></name><name><surname>Anwar</surname><given-names>MF</given-names></name><name><surname>Rahman</surname><given-names>MM-u</given-names></name><name><surname>Jamil</surname><given-names>SS</given-names></name><etal/></person-group><article-title>In vitro toxicity and antidiabetic activity of a newly developed polyherbal formulation (MAC-ST/001) in streptozotocin-induced diabetic Wistar rats</article-title><source> Protoplasma</source><year>2013</year><volume>250</volume><fpage>741</fpage><lpage>749</lpage><pub-id pub-id-type="pmid">23053765</pub-id></element-citation></ref><ref id="B110"><label>110</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhat</surname><given-names>M</given-names></name><name><surname>Kothiwale</surname><given-names>SK</given-names></name><name><surname>Tirmale</surname><given-names>AR</given-names></name><name><surname>Bhargava</surname><given-names>SY</given-names></name><name><surname>Joshi</surname><given-names>BN</given-names></name></person-group><article-title>Antidiabetic properties of Azardiracta indica and Bougainvilleaspectabilis: in vivo studies in murine diabetes model</article-title><source> Evid Based Complementary Altern Med</source><year>2011</year><volume>2011</volume><fpage>561625</fpage></element-citation></ref><ref id="B111"><label>111</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kosta</surname><given-names>S</given-names></name><name><surname>Tiwari</surname><given-names>A</given-names></name></person-group><article-title>Screening and assessment of anti-diabetic and reactive oxygen scavenging (ros), effects of herbs in streptozotacin induced mice</article-title><source> Pharmacol online</source><year>2009</year><volume>3</volume><fpage>695</fpage><lpage>704</lpage></element-citation></ref><ref id="B112"><label>112</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jani</surname><given-names>DK</given-names></name><name><surname>Goswami</surname><given-names>S</given-names></name></person-group><article-title>Screening of the herbal extracts to compare and investigate effect on glucose lowering and anorexic activity in wistar rats</article-title><source> Asian J Pharm Clin Res</source><year>2017</year><volume>10</volume><fpage>160</fpage><lpage>165</lpage></element-citation></ref><ref id="B113"><label>113</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chattopadhyay</surname><given-names>R</given-names></name></person-group><article-title>Possible mechanism of antihyperglycemic effect of Azadirachtaindica leaf extract: part V</article-title><source> J Ethnopharmacol</source><year>1999</year><volume>67</volume><fpage>373</fpage><lpage>376</lpage><pub-id pub-id-type="pmid">10617075</pub-id></element-citation></ref><ref id="B114"><label>114</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muhtadi</surname><given-names>A</given-names></name><name><surname>Irenka</surname><given-names>Y</given-names></name><name><surname>Ayu</surname><given-names>WC</given-names></name><name><surname>Hendriani</surname><given-names>R</given-names></name><name><surname>Zuhrotun</surname><given-names>A</given-names></name></person-group><article-title>Hypoglycemic activity of 10 medicinal plants extract in glucose induced mice</article-title><source> Asian J Pharm Clin Res</source><year>2017</year><volume>4</volume><fpage>2455</fpage><lpage>3891</lpage></element-citation></ref><ref id="B115"><label>115</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Omobowale</surname><given-names>TO</given-names></name><name><surname>Oyagbemi</surname><given-names>A</given-names></name><name><surname>Ugbor</surname><given-names>F</given-names></name><name><surname>Adejumobi</surname><given-names>O</given-names></name><name><surname>Adedapo</surname><given-names>A</given-names></name><name><surname>Yakubu</surname><given-names>M</given-names></name></person-group><article-title>N&#x003c9;-Nitro-L-Arginine Methyl Ester (L-NAME) induced hypertension and cardiorenal oxidative stress: Modulatory effect of the methanolic extract of Azadirachta indica</article-title><source> FASEB J.</source><year>2017</year><volume>31</volume><fpage>1011.10</fpage><lpage>1011</lpage><pub-id pub-id-type="pmid">27934660</pub-id></element-citation></ref><ref id="B116"><label>116</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adejumobi</surname><given-names>O</given-names></name><name><surname>Omobowale</surname><given-names>T</given-names></name><name><surname>Oyagbemi</surname><given-names>A</given-names></name><name><surname>Ayenuro</surname><given-names>O</given-names></name><name><surname>Ola-Davies</surname><given-names>O</given-names></name><name><surname>Adedapo</surname><given-names>A</given-names></name><etal/></person-group><article-title>Amelioration of sodium fluoride-induced hypertension, cardio-renal oxidative stress and genotoxicity by Azadirachta indica through antioxidant and extracellular signal-regulated kinase (ERK) 1/2 signalling</article-title><source> FASEB J</source><year>2017</year><volume>31</volume><fpage>843.12</fpage><lpage>843</lpage></element-citation></ref><ref id="B117"><label>117</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koley</surname><given-names>K</given-names></name><name><surname>Lal</surname><given-names>J</given-names></name></person-group><article-title>Pharmacological effects of Azadirachta indica (neem) leaf extract on the ECG and blood pressure of rat</article-title><source> Indian J Physiol Pharmacol</source><year>1994</year><volume>38</volume><fpage>223</fpage><lpage>225</lpage><pub-id pub-id-type="pmid">7814089</pub-id></element-citation></ref><ref id="B118"><label>118</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>EB</given-names></name><name><surname>Anderson</surname><given-names>CC</given-names></name></person-group><article-title>Cardiovascular effects of Azadirachta indica extract</article-title><source> J Pharm Sci</source><year>1978</year><volume>67</volume><fpage>1476</fpage><lpage>1478</lpage><pub-id pub-id-type="pmid">702308</pub-id></element-citation></ref><ref id="B119"><label>119</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kataria</surname><given-names>M</given-names></name><name><surname>Gupta</surname><given-names>P</given-names></name><name><surname>Gupta</surname><given-names>S</given-names></name></person-group><article-title>Hypolipidaemic and anti-atherogenic activity of petroleum ether extract of neem(Azadirachta indica) seed husk and kernel in streptozotocin-induced diabetic rats</article-title><source> Toxicol Int</source><year>2006</year><volume>13</volume><fpage>105</fpage><lpage>110</lpage></element-citation></ref><ref id="B120"><label>120</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saleem</surname><given-names>T</given-names></name><name><surname>Mumtaz</surname><given-names>U</given-names></name><name><surname>Bashir</surname><given-names>MU</given-names></name><name><surname>Qureshi</surname><given-names>HJ</given-names></name><name><surname>Saleem</surname><given-names>A</given-names></name></person-group><article-title>Comparison of hypoglycemic effects of Azadirachta indica seeds and leaves on alloxan induced diabetes in male albino rats</article-title><source> Pak J Med Health Sci</source><year>2018</year><volume>12</volume><fpage>753</fpage><lpage>756</lpage></element-citation></ref><ref id="B121"><label>121</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nugroho</surname><given-names>AE</given-names></name><name><surname>Sari</surname><given-names>KRP</given-names></name><name><surname>Sunarwidhi</surname><given-names>AL</given-names></name></person-group><article-title>Blood glucose reduction by combination of Andrographis paniculata (Burm ) Ness herbs and Azadirachta indica A Juss leaves in alloxan-induced diabetic rats</article-title><source> J App Pharm Sci</source><year>2014</year><volume>4</volume><fpage>30</fpage><lpage>35</lpage></element-citation></ref><ref id="B122"><label>122</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kar</surname><given-names>A</given-names></name><name><surname>Choudhary</surname><given-names>B</given-names></name><name><surname>Bandyopadhyay</surname><given-names>N</given-names></name></person-group><article-title>Comparative evaluation of hypoglycaemic activity of some Indian medicinal plants in alloxan diabetic rats</article-title><source> J Ethnopharmacol</source><year>2003</year><volume>84</volume><fpage>105</fpage><lpage>108</lpage><pub-id pub-id-type="pmid">12499084</pub-id></element-citation></ref><ref id="B123"><label>123</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maithani</surname><given-names>A</given-names></name><name><surname>Parcha</surname><given-names>V</given-names></name><name><surname>Pant</surname><given-names>G</given-names></name><name><surname>Kumar</surname><given-names>D</given-names></name><name><surname>Dhulia</surname><given-names>I</given-names></name></person-group><article-title>Anti-hyperglycemic activity guided fractionation of aqueous extract of Azadirachta indica on alloxan induced diabetic rats</article-title><source> Int J Res Pharm Sci</source><year>2011</year><volume>2</volume><fpage>488</fpage><lpage>491</lpage></element-citation></ref><ref id="B124"><label>124</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiwari</surname><given-names>BK</given-names></name><name><surname>Pandey</surname><given-names>KB</given-names></name><name><surname>Jaiswal</surname><given-names>N</given-names></name><name><surname>Abidi</surname><given-names>A</given-names></name><name><surname>Rizvi</surname><given-names>SI</given-names></name></person-group><article-title>Anti-diabetic and anti-oxidative effect of composite extract of leaves of some Indian plants on alloxan induced diabetic Wistar rats</article-title><source> J Pharm Invest</source><year>2014</year><volume>44</volume><fpage>205</fpage><lpage>211</lpage></element-citation></ref><ref id="B125"><label>125</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebong</surname><given-names>PE</given-names></name><name><surname>Atangwho</surname><given-names>IJ</given-names></name><name><surname>Eyong</surname><given-names>EU</given-names></name><name><surname>Egbung</surname><given-names>GE</given-names></name></person-group><article-title>The antidiabetic efficacy of combined extracts from two continental plants: Azadirachta indica Juss)(Neem) and Vernonia amygdalina (De )(African bitter leaf)</article-title><source> Am J Biochem Biotechnol</source><year>2008</year><volume>4</volume><fpage>239</fpage><lpage>244</lpage></element-citation></ref><ref id="B126"><label>126</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagashayana</surname><given-names>G</given-names></name><name><surname>Jagadeesh</surname><given-names>K</given-names></name><name><surname>Shreenivas</surname><given-names>PR</given-names></name></person-group><article-title>Evaluation of hypoglycemic activity of neem (Azadirachta indica) in albino rats</article-title><source> J Dent Med Sci</source><year>2014</year><volume>13</volume><fpage>4</fpage><lpage>11</lpage></element-citation></ref><ref id="B127"><label>127</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandra</surname><given-names>A</given-names></name><name><surname>Mahdi</surname><given-names>AA</given-names></name><name><surname>Ahmad</surname><given-names>S</given-names></name><name><surname>Singh</surname><given-names>RK</given-names></name></person-group><article-title>Indian herbs result in hypoglycemic responses in streptozotocin-induced diabetic rats</article-title><source> Nutr Res</source><year>2007</year><volume>27</volume><fpage>161</fpage><lpage>168</lpage></element-citation></ref><ref id="B128"><label>128</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chattopadhyay</surname><given-names>R</given-names></name></person-group><article-title>A comparative evaluation of some blood sugar lowering agents of plant origin</article-title><source> J Ethnopharmacol</source><year>1999</year><volume>67</volume><fpage>367</fpage><lpage>372</lpage><pub-id pub-id-type="pmid">10617074</pub-id></element-citation></ref><ref id="B129"><label>129</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akinola</surname><given-names>OB</given-names></name><name><surname>Dosumu</surname><given-names>OO</given-names></name><name><surname>Akinola</surname><given-names>OS</given-names></name><name><surname>Zatta</surname><given-names>L</given-names></name><name><surname>Dini</surname><given-names>L</given-names></name><name><surname>Caxton-Martins</surname><given-names>EA</given-names></name></person-group><article-title>Azadirachtaindica leaf extract ameliorates hyperglycemia and hepatic glycogenosis in streptozotocin-induced diabetic wistar rats</article-title><source> Int J Phytomed</source><year>2010</year><volume>2</volume><fpage>320</fpage><lpage>331</lpage></element-citation></ref><ref id="B130"><label>130</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akinola</surname><given-names>OB</given-names></name><name><surname>Zatta</surname><given-names>L</given-names></name><name><surname>Dosumu</surname><given-names>OO</given-names></name><name><surname>Akinola</surname><given-names>OS</given-names></name><name><surname>Adelaja</surname><given-names>AA</given-names></name><name><surname>Dini</surname><given-names>L</given-names></name><etal/></person-group><article-title>Intestinal lesions of streptozotocin-induced diabetes and the effects of Azadirachta indica treatment</article-title><source> Pharmacology</source><year>2009</year><volume>3</volume><fpage>872</fpage><lpage>881</lpage></element-citation></ref><ref id="B131"><label>131</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>S</given-names></name><name><surname>Kataria</surname><given-names>M</given-names></name><name><surname>Gupta</surname><given-names>P</given-names></name><name><surname>Murganandan</surname><given-names>S</given-names></name><name><surname>Yashroy</surname><given-names>R</given-names></name></person-group><article-title>Protective role of extracts of neem seeds in diabetes caused by streptozotocin in rats</article-title><source> J Ethnopharmacol</source><year>2004</year><volume>90</volume><fpage>185</fpage><lpage>189</lpage><pub-id pub-id-type="pmid">15013179</pub-id></element-citation></ref><ref id="B132"><label>132</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>A</given-names></name><name><surname>Srivsatava</surname><given-names>R</given-names></name><name><surname>Srivastava</surname><given-names>AK</given-names></name></person-group><article-title>Comparative antidiabetic profile of ayurvedic herbo-mineral formulation and its constituents on normal and streptozotocin-induced diabetic rats</article-title><source> Int J Pharm Sci Rev Res</source><year>2013</year><volume>22</volume><fpage>252</fpage><lpage>263</lpage></element-citation></ref><ref id="B133"><label>133</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ansarullah</surname><given-names>BB</given-names></name><name><surname>Patel</surname><given-names>V</given-names></name><name><surname>Ramachandran</surname><given-names>A</given-names></name></person-group><article-title>Improved glucoregulation, insulin resistance and leptin levels by a polyherbal drug in high fat diet and low dose streptozotocin type 2 diabetes model</article-title><source> Diabetol Croat</source><year>2012</year><volume>41</volume><fpage>3</fpage><lpage>15</lpage></element-citation></ref><ref id="B134"><label>134</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neeraja</surname><given-names>Kamakshi U</given-names></name><name><surname>Srinivasa</surname><given-names>Rao D</given-names></name><name><surname>Yamini</surname><given-names>Suvarchala K</given-names></name><name><surname>Anusha</surname><given-names>K</given-names></name><name><surname>Venkateswara</surname><given-names>Rao B</given-names></name></person-group><article-title>Comparative hypoglycemic study of Aloe vera, Murraya koenigii and Azadirachta indica</article-title><source> Int J Pharmacog Phytochem Res</source><year>2015</year><volume>7</volume><fpage>923</fpage><lpage>927</lpage></element-citation></ref><ref id="B135"><label>135</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakr</surname><given-names>A</given-names></name></person-group><article-title>Changes of hemoglobin content and glucose levels in the blood of Rattus norvegicus by water extracts of Azadirachta indica</article-title><source> Chin J Nat Med</source><year>2012</year><volume>10</volume><fpage>135</fpage><lpage>137</lpage></element-citation></ref><ref id="B136"><label>136</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanni</surname><given-names>O</given-names></name><name><surname>Erukainure</surname><given-names>OL</given-names></name><name><surname>Chukwuma</surname><given-names>CI</given-names></name><name><surname>Koorbanally</surname><given-names>NA</given-names></name><name><surname>Ibeji</surname><given-names>CU</given-names></name><name><surname>Islam</surname><given-names>MS</given-names></name></person-group><article-title>Azadirachta indica inhibits key enzyme linked to type 2 diabetes invitro, abates oxidative hepatic injury and enhances muscle glucose uptake ex vivo</article-title><source> Biomed Pharmacother</source><year>2019</year><volume>109</volume><fpage>734</fpage><lpage>743</lpage><pub-id pub-id-type="pmid">30551526</pub-id></element-citation></ref><ref id="B137"><label>137</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaur</surname><given-names>L</given-names></name><name><surname>Han</surname><given-names>K-S</given-names></name><name><surname>Bains</surname><given-names>K</given-names></name><name><surname>Singh</surname><given-names>H</given-names></name></person-group><article-title>Indian culinary plants enhance glucose-induced insulin secretion and glucose consumption in INS-1 &#x003b2;-cells and 3T3-L1 adipocytes</article-title><source> Food Chem</source><year>2011</year><volume>129</volume><fpage>1120</fpage><lpage>1125</lpage><pub-id pub-id-type="pmid">25212346</pub-id></element-citation></ref></ref-list></back></article>